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Abstract 
Primordial germ cells (PGCs) are the precursors of sperm and egg cells. They arise early in 
mammalian embryonic development and have to translocate from their extraembryonic tissue of 
specification over a significant distance to reach the prospective gonads. The development of 
mammalian PGCs has been investigated mostly in rodents due to the broad availability of mouse 
embryos and the genetic tools established in this species. However, results obtained in mice cannot 
be directly transferred onto the human and other species, and many questions remain concerning 
PGC specification and migration mechanisms. Therefore, this project aimed at investigating germ cell 
development in a non-human primate animal model, the common marmoset monkey (Callithrix 
jacchus). One goal was the in situ characterisation of PGCs in marmoset embryo tissue sections and 
identification of new PGC specific marker proteins. This led to the discovery of Aminopeptidase N 
(ANPEP) expression on the cell surface of marmoset PGCs. 
A study on human embryos demonstrated a close spatial relationship between migrating PGCs and 
peripheral nerves, suggesting a guiding function of the neurons. Therefore, I tested the hypothesis 
that this might be a conserved strategy in mammalian PGC development by analysing sections of 
mouse and common marmoset monkey embryos via immunohistochemical double staining. In both 
investigated species, no spatial association between neurons and migrating PGCs could be detected, 
and the PGCs had reached the gonads before neurons could be detected in the gonads’ vicinity. 
Pluripotent stem cells (PSCs) form the basis of emerging therapies to degenerative diseases since 
they can develop into all tissues of the adult body. PGCs can be considered as potentially pluripotent 
cells, and the culture of mouse and human PGCs was reported to result in the derivation of PSC lines, 
so called embryonic germ cells (EGCs). Therefore, it was the second aim of this study to establish EGC 
lines of the marmoset monkey, and compare them with already available marmoset embryonic stem 
cells and induced pluripotent stem cells. For this purpose, PGCs were isolated from marmoset 
embryos of defined developmental stages and cultured according to published protocols. Even after 
testing several culture approaches, no EGCs could be derived from marmoset PGCs. 
This work provides new insights into PGC translocation in mammals and identifies ANPEP as a novel 
PGC surface protein in the marmoset monkey. However, for the conversions of PGCs to EGCs 
additional cell culture conditions need to be tested.  
__________________________________________________________________________________________ 
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1. Introduction 
1.1 The Marmoset Monkey and Other Non-Human Primate Animal Models 
1.1.1 The common marmoset monkey (Callithrix jacchus) 
The common marmoset monkey (Callithrix jacchus) is a New World monkey that belongs to 
the family of Callithrichidae, together with other marmosets, tamarins and lion tamarins 
(Figure I). The feature that sets the members of Callithrichidae apart from other New World 
monkeys is their possession of claw-like nails known as tegulaes on most of their fingers, 
which are used for climbing and scratching tree bark. They originate from the north-eastern 
coast of Brazil[1]. Marmosets are arboreal animals that eat insects, fruit, seeds and bird eggs, 
but mostly rely on plant exudates such as gum, sap and latex for their diet[1]. They live in 
stable family groups of around nine animals with only one dominant breeding pair to avoid 
incest[2]. The breeding pair relies on the help of the other family members in raising the 
offspring, which are typically born twice per year typically in twin pairs[3]. 
Like human embryos, marmoset embryos can be classified into 23 developmental stages, 
so-called Carnegie stages (CS), based on somite- and limb development[4]. The embryonic 
development of the marmoset is strongly delayed compared to humans or other non-human 
primates[5-7]. At the gestational day (GD) of implantation (~GD 12), this delay between 
marmoset and human is approx. 5 days, and at CS 11 approx. 25 days[6]. Between CS 11 
and 23, however, the speed of development is comparable, meaning that the delay at CS 23 
is still 25 days. After this the development accelerates and the delay is made up for during 
foetal development so that the total gestation time in marmosets is 143 days[6] (compared 
to approx. 267 days in humans). At birth marmosets are particularly locomotorily well-
developed in order to cling to the parents’ back fur. Marmoset offspring are weened after 
approx. 3 months and reach adult size and sexual maturity with approx. 15 months of age[8]. 
Healthy adult common marmosets in captivity weigh between 350 and 550 grams, with 
males being slightly larger than females. Their small body size makes housing and handling 
of common marmosets relatively easy and affordable. There are also no known zoonoses 
that can be transmitted to humans. 
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Marmosets have become an important model species in biomedical research. As mentioned, 
housing and handling of marmosets is relatively easy compared to other non-human 
primates (NHP), while they still exhibit representative primate biology. They are used to 
investigate basic principles of - among others - genetics[9], immunology[10], neurology[11], 
stem cell biology[12-14], embryology[15, 16] and reproduction[17, 18], but have also become a 
popular animal model of human diseases such as Alzheimer’s[19] or autism[20]. Also, the first 
New World monkey genome sequenced was that of a female common marmoset[21]. 
1.1.2 Macaques as non-human primate animal models 
Macaques are a genus of Old World monkeys of the subfamily Cercopithecinae (Figure I), 
with its 23 species distributed all over the world, making macaques the most widespread 
primate genus apart from humans. Some well-known species include the Barbary macaque 
(Macaca sylvanus) which lives in northern Africa and the Rock of Gibraltar, the Japanese 
macaque (M. fuscata), the lion-tailed macaque (M. silenus), the cynomolgus monkey 
(M. fascicularis) and the rhesus monkey (M. mulatta). The last two species are of special 
interest since they are popular animal models in biomedical research[22]. As can be seen in 
Figure I, old world monkeys are relatively closely related to humans. Some research 
questions and medical applications make it indispensable to have an animal model that 
resembles the human as closely as possible, for example for the development of vaccines. 
Since animal experiments on apes are ethically difficult and forbidden in many countries 
including the EU, macaques are the best-established alternative for such a model organism. 
Especially the rhesus monkey is well characterised and widely used in neuroscience and 
infection research as well as transplantation studies and drug testing[23]. In contrast to the 
common marmoset, however, rhesus monkeys have some disadvantages. They only produce 
one offspring per year and take 4 years to reach sexual maturity. They are bigger and more 
aggressive so that, unless they are trained, most handling and treatment actions on the 
animals require anaesthesia, and, most importantly, they can carry zoonoses such as 
Herpes B, which can be lethal for humans[24, 25]. 
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Figure I | Primate evolution. A family tree of primate evolution. The years at the split branches indicate the last 
common ancestor. (Source: https://www.dpz.eu/en/info-center/knowledge/primates/evolution-and-diversity-
of-primates.html. Layout: Luzie Almenräder. All images taken from internal resources or the Wikimedia 
foundation under Creative Commons license (https://commons.wikimedia.org)). 
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1.1.3 Gametogenesis in primates 
Male gametes, the spermatozoa, are constantly produced in the seminiferous tubules of the 
adult testis. During embryonic development, after the germ cell precursors have reached the 
gonadal anlage, they proliferate and in males differentiate into gonocytes and then 
eventually to spermatogonia. The process of spermatogenesis starts after puberty and 
involves several steps that happen gradually from the basement membrane of a tubule 
towards the lumen (Figure II). Spermatogonia are found in direct contact to the basement 
membrane and multiply via a species-specific number of mitotic divisions[26], leading to self-
renewal as well as differentiation into primary spermatocytes. Primary spermatocytes enter 
meiosis I to form secondary spermatocytes and upon completion of meiosis II form the 
so-called round spermatids[27]. During spermiogenesis, the spermatids elongate and mature 
into the spermatozoa or sperm cells, which are released from the germinal epithelium into 
the tubular lumen. Some seasonality in sperm production might occur, for example in the 
rhesus macaque[28], as adaptation to seasonal female oestrus. However, the marmoset as 
well as the human do not show any signs of reproductive seasonality. 
 
Figure II | Spermatogenesis. A) Schematic representation of spermatogenesis in humans and non-human 
primates. B) Histological cross-section of a seminiferous tubule and indication of different cell types. (Source: 
https://commons.wikimedia.org/wiki/File:Figure_28_01_04.jpg)  
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Female meiotic germ cells, so called oocytes, are found in the ovaries. During embryonic 
development, after the germ cell precursors have reached the gonadal anlage, they 
proliferate and in females differentiate into oogonia and then oocytes. The immature 
oogonia enter meiosis, thereby becoming primary oocytes, but arrest in meiosis I before 
birth and remain in this arrested state for several years. After puberty, only one oocyte 
becomes mature during each reproductive cycle, finishes the first meiotic division, enters 
meiosis II and becomes competent for fertilisation. Only after fertilisation occurs, meiosis II 
will be completed. The gamete pool of female primates is thus defined during foetal 
development before birth, and no neo-oogenesis seems to occur in adult females. In 
contrast to humans and rhesus monkeys, the neonatal ovary of the marmoset, however, still 
harbours substantial numbers of pre-meiotic oogonia[29]. This allows investigating primate 
pre-meiotic oocyte development in a non-human primate model by making them more 
easily accessible than in human foetuses. 
1.2 Pluripotent Stem Cells 
Totipotency is defined as the potential of a cell to give rise to a new organism, whereas 
pluripotent cells can differentiate into tissues of all three germ layers (ectoderm, endoderm, 
mesoderm), but not the extraembryonic structures. In vivo, totipotency only occurs in the 
fertilised zygote and after its division in the individual daughter cells up to at least the 
4-cell-stage embryo[30-32]. After this, the cells diverge until the blastocyst stage, where the 
trophectoderm cells will form the extra-embryonic tissues such as the placenta and only the 
pluripotent cells of the inner cell mass (ICM) will develop into the embryo proper[33]. This 
was demonstrated by injection of epiblast cells into genetically different mouse blastocysts 
and resulting chimaera-formation[34]. The culture of ICM cells under appropriate culture 
conditions leads to the maintenance of this pluripotent state also in vitro in indefinitely self-
renewing cell lines. These ICM-derived cell lines were termed embryonic stem cells (ESCs). 
ESC derivation was first achieved in mice in 1981[35, 36], in the rhesus monkey in 1995[37], in 
the common marmoset in 1996[38] and in humans in 1998[39]. The pluripotent state of ESCs 
can be confirmed by their expression of pluripotency factors (namely OCT4A and NANOG), 
the potential to differentiate into tissues of the three germ layers in vitro and in vivo via 
teratoma formation, and by their ability to contribute to a chimeric animal, although this is 
of course not feasible for human ESCs. The discovery of pluripotent stem cells (PSCs) 
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heralded a new age in biomedical research. Since it is theoretically possible to obtain all cell 
types of an organism by directed differentiation of PSCs into the target tissue, they form the 
basis for the development of new cell replacement therapies and tissue engineering 
strategies. Many degenerative diseases are currently untreatable, and it is the hope that 
with PSCs, lost tissue can be replaced, for example heart muscle cells after myocardial 
infarction[40], neurons in degenerative diseases such as Parkinson’s[41], or retina cells in 
macular degeneration[42]. However, the use of ESCs for clinical applications comes with 
ethical concerns since the destruction of embryos is necessary for their derivation. There are 
also some technical issues such as the tumorigenic potential of PSCs and the immune 
rejection of the donor tissue by the host[43]. 
Apart from ESCs, a second pluripotent stem cell type is now available. So called induced 
pluripotent stem cells (iPSCs) were discovered in 2006[44]. It was hypothesised that genes 
important for ESCs, early embryo development and teratoma formation, might be able to 
re-induce pluripotency in differentiated adult cells upon external delivery and gene 
expression. In a laborious but elegant approach, an initial set of 24 ESC-relevant genes was 
identified and delivered into mouse fibroblasts via retro-viral vectors. This resulted in the 
emergence of ESC-like colonies with unlimited proliferative potential. Step by step, one 
factor was removed from the pool of the 24 genes and the ability of the remaining 23 to 
induce ESC-like cells was tested. This way, Yamanaka et al. identified four factors necessary 
and together sufficient for the creation of iPSCs: OCT4, SOX2, C-MYC and KLF4[44]. These 
iPSCs can form viable chimeric mice and can contribute to the mouse germ line, thus 
fulfilling the gold standard of pluripotency[45]. Even more impressive, fully iPSC-derived mice 
were generated using the tetraploid complementation method[46]. Human iPSCs were first 
derived by two groups. While the group around Yamanaka used the same four factors as for 
mouse iPSCs[47], the group around Thomson, who also derived the first human ESCs, used 
OCT4, SOX2, NANOG and LIN28 for successful reprogramming of human fibroblasts[48]. iPSCs 
can now be derived from a variety of adult tissues, such as skin fibroblasts, peripheral 
blood[49] and renal epithelial cells in the urine[50], so that there are no ethical concerns about 
the source of the cells potentially used for therapy. It is also possible to derive 
patient-specific iPSCs so that an autologous cell replacement therapy without immune 
rejection would be possible. 
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For the marmoset monkey, several embryonic stem cell as well as induced pluripotent stem 
cell lines were established and characterised in our lab and are available for further 
research[13, 14]. 
Before iPSCs were available, embryos were the only source for pluripotent stem cell 
derivation. It was therefore attempted by many researchers to find a more accessible and 
less controversial way to obtain PSCs. Several reports were published on the successful 
derivation of pluripotent cells from the neonatal mouse testis[51], and even spermatogonia-
derived PSC from the adult mouse testis were cultured successfully[52, 53]. These were the 
first reports that show the potential of post-natal germ cells to convert back into a 
pluripotent state if they are cultured under the appropriate conditions. Studies on the 
derivation of pluripotent cells from human spermatogonia followed soon after[54-57], as did 
reports on adult ovary-derived pluripotent cells[58]. They are, however, strongly debated as 
of today. After the publication of human spermatogonia-derived PSCs, this was also 
attempted for the common marmoset monkey. While adult spermatogonia could be 
identified and maintained in culture, no pluripotent stem cells appeared[59]. As mentioned 
above, the neonatal marmoset ovary - in contrast to humans - still contains oogonia that 
express pluripotency factors[29]. Therefore, also neonatal ovary culture was attempted. It 
resulted in the appearance of possible oocyte-like cells, but not in the derivation of 
pluripotent stem cells[60]. 
1.3 Primordial Germ Cells 
1.3.1 Definition, epigenetic reprogramming and pluripotency factor expression 
Primordial germ cells (PGCs) arise early in embryonic development and are the 
undifferentiated precursors of sperm and egg cells[61]. They are fundamental in reproduction 
since they are the only cells during embryonic development able to relay their genetic 
information to the next generation. PGCs are considered unipotent since they only give rise 
to the gametes, however they are the only cells in the body which finally form a totipotent 
cell. Germ cells are present during the entire life span of an animal and the germ cell cycle 
closes with the fusion of a spermatozoon and an oocyte to create the zygote. In mammals, 
after the first cell divisions, PGCs arise in the newly formed organism via inducing paracrine 
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signals and translocate to their final destination, the forming gonadal ridges[62]. These will 
then develop into immature ovaries and testes around mid-gestation. 
While in a differentiated cell the epigenome essentially remains the same over the lifespan 
throughout mitosis/meiosis, PGCs undergo significant epigenetic reprogramming via histone 
modification and DNA methylation changes[63]. During embryonic development, after 
implantation of the blastocyst the somatic cells gradually acquire a somatic epigenetic 
profile[63]. This includes inactivation of one X-chromosome in female cells. The DNA in the 
specified PGCs, however, becomes globally demethylated until even the marks on imprinted 
genes are erased, and it also comes to the reactivation of the X-chromosome in female 
PGCs[63]. Re-establishment of maternal or paternal imprinting in the respective gametes 
starts around birth[63]. 
In mammals, the available information about PGCs was gathered mostly in the mouse 
model. In mouse PGCs it was shown that shortly after their specification, pluripotency genes 
are re-upregulated and that, although their function in the germ line remains unclear, OCT4, 
SOX2 and NANOG are necessary for germ cell survival[64-66]. This dependency on pluripotency 
factors led to the hypothesis that PGCs can actually be considered as potentially pluripotent, 
and that in fact there is a latent cycle of pluripotency, from the inner cell mass over PGCs 
and through fertilisation over the zygote back to the ICM, which is sustained by a common 
transcription factor network[67]. Furthermore, mouse PGCs express the surface marker 
SSEA-1, which can be used to select and purify the cells[68], but do not seem to express other 
known ESC markers such as SSEA-3, -4, TRA-1-60 or TRA-1-81[69]. While in mice the 
investigation of PGCs is now relatively easy due to possibilities of transgenesis and 
reporter-genes, the identification of primate PGCs is still based on morphological criteria and 
immunohistochemical detection of PGC marker proteins. 
Due to the actual lack of early human embryonic material, studies on human PGCs are rare 
and some important studies even date back as far as the early twentieth century[70, 71]. 
During that time, only histological observations were possible. Human PGCs could be 
identified in the yolk sac at the base of the allantois by the end of the third week of 
gestation, showing already at that time their extra-gonadal origin[70, 71]. From there, they are 
incorporated into the gut epithelium, where they can be found in gestational week four, 
invade the gut mesenchyme in week five and can be found in the developing genital ridges 
from the sixth week of gestation onward[61, 72]. Apart from the early description of human 
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PGC tissue locations, only little information was available for a long time. In 1953, the 
expression of Alkaline Phosphatase (AP) was detected on human PGCs[73]. As for the surface 
markers expressed on human ESCs, human PGCs also seem to express SSEA-1, -3 and -4, c-Kit 
and CXCR4, but not TRA-1-60 or TRA-1-81[74, 75]. More recently, attractive cell culture 
systems have become available as an alternative for in vivo human PGCs to make up for the 
lack of information on the molecular mechanisms behind human germ cell 
development[76, 77]. 
For the marmoset monkey, there is only one recent study available on PGCs. Aeckerle et al. 
investigated marmoset embryos of different developmental stages and confirmed that 
marmoset PGCs can be identified via the expression of the pluripotency factors OCT4A, 
LIN28, NANOG and SALL4, and also express the germ cell marker VASA[16]. A study by Sasaki 
et al. published in 2016 investigated PGCs in embryos of the cynomolgus monkey (Macaca 
fascicularis)[7]. In cynomolgus monkeys, the late embryonic Carnegie stages (CS) 17-23 are 
already formed between gestational day (GD) 35 – GD 55, which is in strong contrast to the 
common marmoset, where GD 50 approximately corresponds to CS 10, and CS 18 is reached 
approximately around GD 75[16]. During this developmental period, PGCs of the cynomolgus 
monkey (cyPGCs) are found in the embryonic gonad and express the transcription factors 
BLIMP1 and TFAP2C, the known pluripotency factors (OCT4, SALL4, NANOG, LIN28), germ 
cell specific proteins DDX4 (VASA) and DAZL, as well as the surface proteins TRA-1-60, 
TRA-1-81, D2-40 and c-KIT[7]. Gonadal cyPGCs also express SOX17. In contrast to its role in 
pluripotency and embryonic stem cells, and in contrast to mouse PGCs, primate PGCs do not 
seem to express SOX2[7, 78, 79]. 
1.3.2 PGC specification 
In animals, there are two mechanisms by which germ cells are specified. One way is via 
so-called germ plasm[80]. The unfertilised oocyte of most animals exhibits an asymmetrical 
distribution of mRNAs and proteins, and therefore after cell division the daughter cells 
inherit a different fate via the differential presence of signal molecules. The daughter cells 
which inherited the cytoplasmic portion of the oocytes that made up the germ plasm will 
therefore become germ cells. In birds and mammals, however, the unfertilised oocyte is 
rather symmetric or, in other words, no equivalent of germ plasm has been identified so far, 
and the initial cell divisions result in equivalent totipotent daughter cells that all have the 
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potential to become germ cells. Therefore, PGCs have to be specified via inducing signals of 
neighbouring cells that will set them apart from somatic cells. In mice, PGCs are specified via 
inducing signals from cells of the proximal posterior epiblast starting at embryonic day 
(E) 6.0[62], and an initial population of 30 – 50 PGCs expressing distinctive markers has 
formed in the extra-embryonic mesoderm by E 7.25[81]. The signalling cascade in mouse 
PGCs is believed to start with bone morphogenic protein 2 (BMP2) and BMP4, which induce 
the expression of B-lymphocyte-induced maturation protein 1 (BLIMP1, also known as PR 
domain-containing 1 (PRDM1)), closely followed by PRDM14, which finally leads to the 
upregulation of PGC-specific genes Tfap2c, fragilis and stella. All of these markers can be 
detected in early mouse PGCs, as can the expression of Tissue Nonspecific Alkaline 
Phosphatase (TNAP)[82]. 
The knowledge about mammalian PGC specification was obtained mainly in mice. These 
results can however not be translated directly onto humans and other primates. For 
example, the tissues involved in mouse PGC specification, namely the extraembryonic 
ectoderm, seem to have no clear counterpart in humans[75]. Due to the lack of suitable 
human embryonic material, pluripotent stem cell culture studies are currently the only 
alternative to investigate human PGCs. Irie et al. in 2015 managed to derive human PGC-like 
cells (hPGCLC) from human pluripotent stem cells in vitro and thus were able to investigate 
the molecular mechanisms behind human PGC specification[76]. They found that SOX17, 
which is a critical transcription factor for the endodermal germ layer[83, 84], is also the key 
regulator for human PGC induction. SOX17 is detectable in hPGCLCs even before BLIMP1[76]. 
The role of BLIMP1 in hPGCLCs seems to be the suppression of endodermal and other 
somatic genes downstream of SOX17, which is different from its role in mice, where BLIMP1 
seems to be the key regulator of PGC fate[85]. 
Until recently, no in vivo data was available on primate PGC specification. The earliest data 
available on human and primate PGCs described them during the migratory phase in 
gestational weeks 3-4, where they were initially found in the yolk sac endoderm. As 
described above, Sasaki et al. investigated PGC specification in embryos of the cynomolgus 
monkey and shed first light on the involved tissues and mechanisms[7]. After establishing a 
panel of gonadal cyPGC markers, the combinatorial detection of these validated markers 
allowed them to identify also migrating PGCs, and they finally traced them back to their 
origin in early post-implantation embryos of GD 11 to GD 17. It was shown that 
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SOX17/TFAP2C-double positive PGCs arise in the dorsal posterior amnion prior to 
gastrulation, and no PGCs were detected within the epiblast[7]. 
1.3.3 PGC migration 
It has been known for a long time even for humans that although the final location of the 
PGCs is the genital ridges, these cells are of extra-gonadal origin[61, 70-72]. In mice, after the 
PGCs are specified in the proximal epiblast, they have to transit via the hindgut endoderm 
and the dorsal mesentery towards their destination, the urogenital ridges. Between E 9.5 
and E 10.5 the PGCs reach the genital ridges developing laterally to the aorta where they 
form the embryonic gonads[86]. As described above, in primate embryos PGCs seem to arise 
in the amnion[7] and they, too, translocate to the genital ridges via the dorsal/caudal wall of 
the yolk sac, the hindgut endoderm and the dorsal mesentery. In the cynomolgus monkey, 
they showed that most markers detected on the gonadal PGCs are also already present on 
the migrating PGCs, with the exception of DDX4 (VASA) and DAZL[7]. For the marmoset, so far 
only one study on migrating PGCs is available. While it confirms the translocation route via 
hindgut and mesentery, it also shows a wide spatio-temporal distribution of PGCs during 
embryonic development, and proposes a translocation model which is based on 
morphogenetic changes of the tissues containing the PGCs rather than long-range PGC 
migration[16]. 
The exact mechanism of this PGC translocation from their ventral extraembryonic tissue of 
specification towards the dorsal body wall of the developing embryo is indeed still debated. 
Passive movement of the cells via morphogenetic changes of the surrounding tissues may 
play an important role in transporting the PGCs closer to their destination[16, 87]. However, in 
order to move from the hind- and midgut to the gonadal ridges, active PGC migration has to 
be involved. Images of human PGCs published by Politzer as early as 1933 show cytoplasmic 
protrusions on the cells, suggesting an amoeboid migratory movement[72]. Molyneaux 
et al.[88] tagged Oct4 with GFP in genetically modified mice and thus were able to visualise 
and take time-lapse videos of PGCs during the stages of their migration. They showed that 
the PGCs exhibit active locomotion, however this does not seem to be an intrinsically 
directed movement. Rather, it was proposed that the PGCs have to follow contact guidance 
clues or chemotactic signals in order to find the way to their site of function. Factors 
Introduction 
 
 
29 
proposed to be involved in chemotaxis of PGCs include tumour growth factor β (TGFβ)[89], 
stromal-derived factor 1 (SDF1 or CXCL12)[90, 91] and stem cell factor (SCF; or kit ligand)[92, 93]. 
It was first suggested by Hoyer et al. that human PGCs might not be guided only by gradients 
of signalling molecules, but also by anatomical structures, namely nerve fibres. This was 
based on a strong spatial association of human PGCs with autonomic nerve fibres of the 
dorsal mesentery in a study on c-Kit and SCF distribution in human embryos[93]. This 
hypothesis was further investigated by Møllgard et al.[94]. In 4 – 8 weeks post conception (pc) 
human embryos they identified migrating PGCs and neurons and found that indeed, a large 
proportion of PGCs were located within bundles of autonomic nerve fibres on their route 
from the dorsal mesentery to the gonadal ridges. They also observed by 
immunohistochemical marker staining that the innervation of the human gonadal ridges 
starts between 29 and 33 days pc, the same time that the first PGCs arrive at their 
destination. They concluded from their data that in human embryos the PGCs preferentially 
follow peripheral autonomic nerve fibres during their translocation from the dorsal 
mesentery to the gonads[94]. 
1.4 Primordial Germ Cell Culture and Embryonic Germ Cell Derivation 
1.4.1 Mouse EGCs 
On feeder cells, isolated mouse PGCs proliferate for several days but eventually cease their 
proliferation and decrease in cell number[95, 96]. Mouse embryonic germ cells (EGCs) were 
initially discovered as a result of long-term PGC culture experiments. Two groups around 
Matsui et al. and Resnick et al. discovered at approximately the same time that the 
combination of several growth factors is required to maintain PGC proliferation and that this 
leads to the formation of pluripotent cell colonies[97, 98]. These were termed EGCs in analogy 
to the term embryonic stem cells (ESCs), which are derived from the inner cell mass of the 
blastocyst. To be more specific, it was known that the cytokine leukaemia inhibitory factor 
(LIF) stimulates PGC proliferation in culture[95] and that the membrane-bound form of stem 
cell factor (SCF) is required for PGC survival in vitro[99, 100]. But only the addition of basic 
fibroblast growth factor (bFGF) induced long-term PGC proliferation[97, 98]. 
It was soon accepted that under the appropriate culture conditions, PGCs will spontaneously 
reprogram and convert back to a pluripotent state, which led to the publication of several 
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detailed culture protocols[68, 101, 102]. From the beginning, it was known that mouse PGCs 
express the enzyme Alkaline Phosphatase (AP) and that AP-expression is also a hallmark of 
pluripotent stem cells, which is why AP-detection served as a tool to identify PGCs and 
EGCs[97]. While PGCs cannot contribute to chimaera-formation, the injection of mouse EGCs 
into blastocysts will lead to incorporation of these cells into the new organism and they even 
contribute to the germ line, this being the ultimate proof of their pluripotent potential[103]. 
1.4.2 Human EGCs 
Not long after the discovery of mouse EGCs, the same protocols were tested for human 
PGCs, leading to the establishment of human EGCs[104-106]. Same as the mouse EGCs, human 
EGCs are derived by dissociation of the embryonic genital ridges and then plating the cells on 
mouse feeder cells expressing membrane-bound SCF. AP-positive colonies appear and can 
be expanded and passaged as EGCs. Human EGCs apparently are generated relatively easy, 
however, in contrast to initial claims, it seems difficult to maintain them as a stable cell-line 
through extended passage[105, 106]. 
Nevertheless, there have been some promising reports on the therapeutical use of human 
EGCs. Kerr et al. reported in 2003 that human EGC-derived cells could restore motor neuron 
function in paralysed rats[107]. Frimberger et al. reported increased regeneration of injured 
rat bladders after hEGC transplantation[108], and Yu et al. differentiated human EGCs into 
cardiomyocytes and used them to treat acute myocardial infarction in rats[109]. 
Apart from human and mouse, also EGC lines of rat, buffalo, pig and goat were reported[68]. 
The EGC derivation of rabbit, sheep, cow and baboon was intended, but no successful EGC 
line was established[68]. 
1.5 Rationale and Aim of the Study 
Part I 
As explained in chapter 1.3.3, the mechanisms behind mammalian PGC migration are still 
debated. A study by Møllgard et al. reported that in human embryos, PGCs are guided 
towards their destination by peripheral nerve fibres[94]. One aim of the present study was 
therefore to investigate whether this method of PGC guidance and transition could be 
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observed also in other mammalian species and whether it might represent an evolutionary 
conserved, i.e. general strategy of mammalian germ cell development. In order to answer 
the study question, I investigated embryos of different developmental stages from the 
mouse and a non-human primate, the marmoset monkey, covering the phase from early 
PGC migration to their arrival in the gonadal ridge. Embryo sections were 
immunohistochemically co-stained for tubulin beta-3 chain (TUBB3) to visualise neurons and 
Octamer-binding protein 4 (OCT4) as marker for PGCs, and the distance between each PGC 
and the closest detectable neuron was measured in order to make a statement about their 
spatial relationship. 
Investigating primate germ cell development is of interest under several aspects, for 
example for reproductive medicine. As described above, the study of human germ cell 
development is difficult, and the marmoset monkey might be a valuable alternative. While 
much is known about mouse PGCs, there is only paper available on the common marmoset 
PGC development, describing four intracellular markers for their identification[16]. It was 
therefore another goal of this study to test the expression of several candidate proteins 
including surface markers of PGCs in the marmoset embryo. One candidate is the 
transcription factor SOX17. While SOX17's functions in the formation and maintenance of 
definitive endoderm[83], vascular endothelium[110], and foetal hematopoietic stem cells[111] 
are well established, its role in germ cells is less clear. A recent publication reported it to be 
the key regulator of germ cell fate in the human[76], and so its expression in (early) marmoset 
germ cells was investigated. 
Part II 
As described in chapter 1.3, PGCs can be considered to be inherently pluripotent due to their 
expression of pluripotency factors. Their close relationship to embryonic stem cells is 
corroborated by their potential, as has been shown convincingly at least in the mouse, to 
spontaneously form pluripotent cell lines under the appropriate culture conditions, which 
are then termed embryonic germ cells (EGCs). As explained above, pluripotent stem cells 
(PSCs) are highly interesting for the prospect of using them in cell replacement therapies, 
and PSCs of different origins might have different advantages and disadvantages, probably 
depending on their epigenetic properties. Embryonic stem cells (ESCs) as well as induced 
pluripotent stem cells (iPSCs) of the common marmoset monkey (Callithrix jacchus) are 
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already available in our laboratory. It was therefore my aim to establish a third pluripotent 
stem cell type from marmoset PGCs, characterise the resulting EGC lines and compare them 
to the already available ESCs and iPSCs with regard to their potential use as a source for cell 
replacement therapies. As described above, human and mouse EGCs can be derived from 
genital ridge culture and protocols are available in the literature. Since there are no recent 
human EGC culture reports, and the culture method is similar for both species, I based my 
experiments on publications by Durcova-Hills et al.[101], De Miguel et al.[68] and Leitch 
et al.[102]. 
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2. Results 
2.1 Part I – In situ studies of PGC development 
2.1.1 PGCs do not migrate along nerve fibres in marmoset monkey and mouse embryos 
2.1.1.1 PGC localisation in the common marmoset monkey (Callithrix jacchus) 
Eight common marmoset embryos of different developmental stages (gestational day 
(GD) 65, 68, 72, 75, 90) were analysed in this study, approximately representing the Carnegie 
stages 15-23. A list of the specimens used for this part of the project is given in Table 1. A 
total of 853 PGCs were counted on 30 histological sections. 
The PGCs were first grouped according to the anatomical compartment they were found in 
(Figures 1 and 2). Looking at the total cells, approx. 3 % of PGCs were detected in the 
epithelium of the gut, 12 % either in the gut mesenchyme, the dorsal mesentery or the 
peri-aortic region and 14 % of PGCs were attributed to the dorsal body wall. With 71 % the 
majority of PGCs was located in the developing genital ridges, or the mesonephros and 
gonadal precursors in more developed embryos (i.e. GD 75 onwards). Separating the 
sections according to the gestational day of the embryos, the proportion of PGCs that have 
reached the gonad expectedly increased from 13.7 % on GD 65 over 47.7 % on GD 72 to 
93.3 % on GD 90. 
Table 1 | Marmoset monkey (Callithrix jacchus) embryos used in this study. 
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Figure 1 | PGC locations in the common marmoset monkey embryo. Immunohistochemical double staining of 
OCT4A (brown) and TUBB3 (pink). A) Representative sagittal overview section of a GD 65 embryo. B) Higher 
magnification of area of prospective gonad in A). C) Sagittal section of a GD 65 embryo (different than shown 
in A). Black arrows highlight migrating PGCs in the gut mesenchyme. D) Developing gonad in a GD 90 embryo 
containing post-migratory PGCs. Bv: Brain vesicle, G(l): Gut (lumen), H: Heart, M: Mesenchyme, Nt: Neural 
tube, Nl: Neural lumen, Oe: Oesophagus, Pc: Plexus choroideus, U: Umbilical cord. The asterisks mark the 
developing genital ridge. Scale bar ≙ 3 mm (A), 300 µm (B-D). 
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Figure 2 | Graphical representation of PGC locations in the common marmoset monkey embryo. Tissue 
locations of PGCs in all investigated slides, separately analysed for each gestational day, n = number of cells 
available for analysis. 
From each detected PGC the distance to the closest neuron was measured and the results 
divided into three groups: (I) Cells more than 50 µm away, (II) cells that were found between 
50 – 20 µm from the nearest neuron and (III) cells with a distance of less than 20 µm. 
The main finding of my examination was that for over 96 % of the total detected PGCs no 
nerve cells could be detected within a distance of 50 µm. 1.64 % of the total PGCs were 
found in the distance range of 50 – 20 µm and only 1.75 % (15 cells total) less than 20 µm 
away. Of these 15 cells only two were found in direct contact with a neuron (Figure 3). Sub-
dividing the data according to the gestational day of the embryos does not reveal any 
differences in the PGC-neuron distance: at least 95.3 % of PGCs were found at a distance 
> 50 µm (GD 72), 0.8 – 2.8 % are found in the 50 – 20 µm distance range, and only max. 
3.9 % of PGCs could be detected less than 20 µm from the closest neuron (GD 72) (Figure 4). 
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Figure 3 | PGC-neuron distance in the common marmoset monkey embryo. Representative sagittal section of 
a GD 72 marmoset monkey embryo. Immunohistochemical double staining of OCT4A (brown) and TUBB3 
(pink). Inlay shows an exemplary distance measurement of a migratory PGC to the closest neuron. Green arrow 
highlights a PGC in direct contact with a neuron. Scale bar ≙ 200 µm. 
 
Figure 4 | Graphical representation of the PGC-neuron distance in the marmoset embryo. The distance 
between the observed PGCs and the respectively closest detectable neuron, separately analysed for each 
gestational day, n = number of cells available for analysis. 
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2.1.1.2 PGC localisation in the mouse embryo 
In the mouse, a total of 3482 PGCs were counted on 64 sections of 8 embryos of consecutive 
embryonic days (E 8.5 – E 11.5). The list of mouse samples for this study can be found in 
Table 2. Looking at mouse embryos provided the advantage of a more systematic 
investigation of PGC migration, as migration happens over a shorter time than in the 
marmoset. The developmental span of E 8.5 – E 11.5 covers almost the entire range of PGC 
migration. Additionally, it allowed to better follow the neuronal development and draw 
conclusions on potential interactions with PGC migration. This observation could not be 
made in the marmoset embryos since the neuronal development (but not the PGC 
translocation!) in the earliest investigated stage (GD 65) had already progressed further than 
that in the oldest investigated mouse embryo (E 11.5). 
Table 2 | Mouse embryos used in this study. 
 
Again, PGCs were first classified according to their tissue location (Figures 5 and 6). On E 8.5 
98.25 % of PGCs were found either in the gut epithelium or the mesenchyme surrounding 
the gut. On E 9.5 the majority of PGCs (84.77 %) were migrating through the gut 
mesenchyme and the mesentery. 7.28 % were found in the gut epithelium and 7.95 % had 
already reached the location where the genital ridges started to form. By E 10.5 the genital 
ridges were clearly distinguishable from the surrounding tissue, and while they now 
harboured most of the detected PGCs (84.67 %), 9.17 % of PGCs were found in the gut 
mesenchyme, the mesentery or the region surrounding the aorta. By E 11.5 by far the most 
of the PGCs (> 90 %) had reached the developing gonads. The remaining cells were detected 
mostly in the peri-aortic region or the mesentery. These findings reflect the PGC migration / 
translocation process. 
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Figure 5 | PGC tissue locations in the mouse embryo. A-D) Sections of different embryonic stages 
immunohistochemically stained for OCT4. A) Representative transversal section of an E 8.5 embryo. 
B) Representative sagittal section of an E 9.5 embryo. C) Representative transversal section of an E 10.5 
embryo. D) Representative transversal section of an E 11.5 embryo. A: Dorsal aorta, Gl: Gut lumen, 
M: Mesenchyme, Mes: Mesentery, Nt: Neural tube. The asterisks mark the developing genital ridge. PGCs are 
highlighted and colour-coded according to the tissue they were detected in. Scale bar ≙ 90 µm (B), 
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200 µm (A, C, D). E) Graphical representation of PGC numbers in the mouse embryo. Number of detectable 
PGCs per tissue section in all investigated slides, separately analysed for each embryonic day. 
 
Figure 6 | Graphical representation of PGC tissue locations in the mouse embryo. Tissue locations of PGCs in 
all investigated slides, separately analysed for each embryonic day, n = number of cells available for analysis. 
Approximately 2 % of total PGCs were also found at ectopic regions (regions that deviate 
from the “normal” migration route) such as the neural tube. 
Measuring the distance of each PGC to the closest neuron revealed results similar to those 
obtained in the marmoset embryos (Figures 7 and 8): On E 8.5 only 0.88 % of cells were 
found at a distance of less than 20 µm from a neuron and 0.44 % in the distance range of 50 
– 20 µm (2 and 1 cell in total, respectively). 98.68 % of cells were more than 50 µm away. 
This percentage even increased in the data obtained on E 9.5, where not a single PGC was 
detected within a 50 µm distance of a neuron. On E 10.5 and E 11.5 the results remained 
similar, with 98.12 % and 95.02 % of cells detected in the > 50 µm distance category, 
respectively. On E 11.5 the proportion of PGCs that were found closer to a neuron increased 
slightly, with 2.8 % and 2.9 % per category, respectively. 
In the mouse embryos we observed a strong increase in PGC number between E 10.5 and 
E 11.5 (for comparison see Figure 5 C/D), which indicates the onset of intense PGC 
proliferation. Clusters of several PGCs could be found outside the gonad on E 11.5, whereas 
only single cells were observed on the days before. The increase in PGC numbers is also 
quantified in Figure 5 E. 
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Figure 7 | PGC-neuron distance in the mouse embryo. A+B) Sagittal and transversal section of E 11.5 mouse 
embryos immunohistochemically double stained for OCT4 (brown) and TUBB3 (pink). Exemplary distance 
measurements between representative PGCs and the respectively closest detectable neuron. 
Scale bar ≙ 80 µm (A), 60 µm (B). Asterisk marks the prospective gonad. PGCs are highlighted and colour-coded 
according to the tissue they were detected in. 
 
Figure 8 | Graphical representation of PGC-neuron distance in the mouse embryo. The distance between the 
observed PGCs and the respectively closest detectable neuron, separately analysed for each embryonic day, 
n = number of cells available for analysis. 
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2.1.1.3 Comparing neuronal development between mouse and marmoset embryos 
Figure 9 A-C exemplarily shows an E 10.5 mouse embryo double stained for TUBB3 and OCT4 
as well as single stainings of the two markers. While OCT4-positive PGCs were clearly 
detectable in the gonad, no TUBB3 signal was visible in neither the gonad nor the adjacent 
tissue. Figure 10 A-D shows the neuronal development observed in mouse embryos by 
TUBB3 staining: On E 8.5, neurons were clearly visible in the developing brain and started to 
appear in the neural tube (Figure 10 A). The intensity of these signals increased on the E 9.5 
embryos (Figure 10 B). Interestingly, a clear gradient of TUBB3-positive neurons in the 
neural tube from cranial to caudal was observed between those two embryonic days (shown 
in Figure 9 D). On E 9.5, first ganglia started to appear in the mesenchyme around the gut, 
which did not show any histological signs of smooth muscle differentiation at this stage. 
While the signals in the aforementioned tissues became more pronounced on E 10.5, 
neurons also started to appear in the region around the aorta (Figure 10 C). This was best 
recognisable on the transversal embryo sections. Presence of neurons in the mesentery was 
not observed but cannot be excluded. Most important for this study was the finding that by 
E 11.5 there was still no innervation of the gonad detectable (Figure 10 D), although 90 % of 
all PGCs were present in the gonad (Figure 6). A summary of the observed TUBB3 signal 
intensity in different tissues at different developmental stages in the mouse embryo is given 
in Table 3. 
These findings regarding the spatio-temporal development of the peripheral nervous system 
in the mouse are different from the marmoset embryos, where at the earliest investigated 
stage (GD 65) the neuronal development had already progressed further than that in the 
latest mouse embryo as judged from TUBB3 staining. In the GD 65 marmoset embryos, 
TUBB3 staining gave a clear signal in the brain, neural tube, ganglia, ganglia of the gut, the 
gut epithelium and the gut mesenchyme (Figure 1 A). There was also a strong signal in the 
epithelia of the mesonephros. However, importantly, also in the marmoset embryos, there 
was no signal detectable in the gonads of even the oldest investigated embryo (GD 90, 
Figure 1 D), confirming the mouse data that PGCs are present in the developing gonad 
before any nerve fibres can be detected in the vicinity of the embryonic gonad. 
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Figure 9 | Neuronal development observed in the mouse embryo I. A) Representative sagittal overview 
section of an E 10.5 embryo immunohistochemically double stained for OCT4 (brown) and TUBB3 (pink). 
Scale bar ≙ 2 mm. B+C) Higher magnification of the area highlighted in A), immunohistochemically stained for 
OCT4 (B) or TUBB3 (C). Scale bar ≙ 300 µm. D) Representative transversal section of an E 9.5 embryo 
immunohistochemically stained for TUBB3. Bv: Brain vesicle, H: Heart, L: Liver, Nt: Neural tube, Nt(cau): Neural 
tube in the caudal region of the embryo, Nt(cra): Neural tube in the cranial direction of the embryo. The 
asterisks mark the developing genital ridge. Scale bar ≙ 300 µm. 
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Figure 10 | Neuronal development observed in the mouse embryo II. Sections of different embryonic stages 
immunohistochemically stained for TUBB3. Left panel: Overview of the respective stage in lower magnification. 
Right panel: Higher magnification of the left image. A) Representative transversal section of an E 8.5 embryo. 
B) Representative transversal section of an E 9.5 embryo. C) Representative transversal section of an E 10.5 
embryo. D) Representative transversal section of an E 11.5 embryo. A: Dorsal aorta, Gl: Gut lumen, Nl: Neural 
lumen, Nt: Neural tube. The asterisks mark the developing genital ridges. Pink circles highlight appearing 
neurons. Scale bar ≙ 600 µm (D left panel), 400 µm (B left panel), 300 µm (A+C left panel), 200 µm (all images 
in right panel). 
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Table 3 | The observed TUBB3 signal intensity in different tissues at different developmental stages in the 
mouse embryo. 
 
In order to confirm that TUBB3 staining reveals all present neurons, marmoset embryos 
were also stained for microtubule-associated protein 2 (MAP2), which is another protein 
specifically expressed in neurons (Source: The Human Protein Atlas; 
https://www.proteinatlas.org/ENSG00000078018-MAP2/tissue). Figures 11 and 12 show 
that both TUBB3 and MAP2 are expressed by almost the same cells, with the difference that 
TUBB3 seems to be additionally expressed in epithelial cells of the gut and kidney 
(Figure 12 A). 
 
Figure 11 | MAP2 and TUBB3 staining pattern is comparable in the marmoset monkey embryo I. 
Immunohistochemical staining of tissue sections in a marmoset GD 71 embryo for TUBB3 (A) and MAP2 (B). 
Nt: Neural tube. Asterisks mark the developing urogenital ridge. Scale bar ≙ 600 µm. 
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Figure 12 | MAP2 and TUBB3 staining pattern is comparable in the marmoset monkey embryo II.  
Immunohistochemical staining of tissue sections in a marmoset GD 85 embryo for TUBB3 (A) and MAP2 (B). 
Ad: Adrenal gland, G: Gut, H: Heart, K: Kidney, Nt: Neural tube, Pc: Plexus choroideus, S: Stomach. 
Scale bar ≙ 4mm (top images), 500 µm (bottom images). 
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Figure 13 | Characterisation of OCT4A antibody via Western Blot. Top image shows chemiluminescence 
antibody signal, middle image shows the blot membrane under normal light for size comparison, bottom image 
shows the blot membrane stained with Amido Black as control for the presence of protein in the sample. 
CP: Cytosolic protein fraction, NP: nuclear protein fraction. A single, distinct band of the expected size is 
detected in the nuclear protein samples of marmoset and rhesus monkey embryonic stem cells as well as the 
cytosolic protein sample of the rhesus ESCs. No band is visible in the liver sample which was used as negative 
control. 
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Figure 14 | Characterisation of TUBB3 antibody via Western Blot. Middle image shows chemiluminescence 
antibody signal, top image shows the blot membrane under normal light for size comparison. A single, distinct 
band is detected in the marmoset monkey brain protein sample. No band is visible in the marmoset liver 
sample, which was used as negative control. Bottom image shows blot membrane stained with Amido Black as 
control for the presence of protein in the samples. 
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To further corroborate the specificity of the chosen antibodies, they were analysed via 
Western Blot (WB). OCT4A as a pluripotency factor is supposed to be highly expressed in 
embryonic stem cells (ESCs) of marmoset and rhesus monkey, and not expressed in the liver, 
which was chosen as negative control. The WB revealed one distinct band in the ESC protein 
samples and no signal in the liver sample (Figure 13) at the apparent molecular weight of 
~50 kDa. The calculated molecular weight of OCT4A is 38.6 kDa. For the TUBB3 WB, protein 
samples of marmoset brain and liver were used. Also in this blot, one distinct band around 
the calculated weight of 50.4 kDa was revealed in the positive control and no signal was 
detectable in the negative control (Figure 14), confirming the specificity of the antibodies. 
2.1.2 SOX17 expression in the germ line of non-human primates 
2.1.2.1 SOX17 in early marmoset monkey (Callithrix jacchus) PGCs 
SOX17 is a transcription factor that has been shown to be the key regulator of germ cell fate 
in the human, where it is the first gene to be expressed in PGCs and induces the germ cell 
specification process[76]. I therefore wanted to investigate whether it is also detectable in 
early marmoset PGCs. Sequential sections of GD 49 and GD 53 marmoset embryos were 
stained alternatingly for OCT4A to identify the PGCs, and SOX17. As shown in Figure 15, 
corresponding SOX17 and OCT4A signal could be observed in two different sets of 
neighbouring tissue sections. It is however difficult to ultimately determine via IHC whether 
the signal is detected in the same cell. In the GD 53 embryo, SOX17 staining produced a lot 
of background, which is why many slides were not available for analysis. Figure 16 shows a 
slide of this embryo, but no SOX17 signal was detected in the area with OCT4A-positive cells. 
Staining marmoset embryo sections of GD 65 and GD 75 shows that there was clearly no 
SOX17 signal detectable in OCT4A-positive PGCs at these stages (Figure 17). 
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Figure 15 | SOX17 expression in the GD 49 marmoset embryo. Immunohistochemistry of sequential tissue 
sections of a GD 49 marmoset embryo alternatingly stained for SOX17 and OCT4A as a marker for PGCs. 
A) Two sequential sections with corresponding SOX17 and OCT4A-positive cells. B) Three sequential sections 
with corresponding SOX17 and OCT4A-positive cells. The right panel of B) shows a different area on the same 
sections with two corresponding SOX17 and OCT4A-positive cells. Scale bar ≙ 200 µm. 
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Figure 16 | SOX17 expression in the GD 53 marmoset embryo. Immunohistochemistry of transversal 
sequential tissue sections of a GD 53 marmoset embryo alternatingly stained for OCT4A as a marker for 
PGCs (A) and SOX17 (B). The blue circle highlights an area with 6 OCT4A-positive PGCs. The red circle highlights 
the same area on the SOX17-stained slide, where no SOX17-positive cells are detectable. Scale bar ≙ 300 µm 
(left panel), 200 µm (right panel). 
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Figure 17 | SOX17 expression in the GD 65 and GD 75 marmoset embryo. Immunohistochemistry of tissue 
sections of a GD 65 (A) and a GD 75 (B) marmoset embryo stained for OCT4A as a marker for PGCs (left panel) 
and SOX17 (right panel). Inlay in A) shows IgG isotype control. Gm: Gut mesenchyme. Asterisks mark 
developing genital ridges. Scale bar ≙ 200 µm. 
2.1.2.2 Differential SOX17 expression in NHP gonads 
Figure 18 shows SOX17 staining in the marmoset neonatal and adult ovary, respectively. It 
includes staining of SALL4, which is a pluripotency associated transcription factor in the early 
embryo and later on detected in germ cells and haematopoietic stem cells, and SSEA-5, 
which is also a marker of pluripotent stem cells[112] but whose role in germ cells is not yet 
determined. While SALL4 was still expressed in the neonatal ovary and not expressed in 
adult oocytes anymore, it was the other way around with SOX17, which was not detectable 
in the neonatal ovary but specifically expressed in adult oocytes. SSEA-5 could also be 
detected in adult oocytes, and was also expressed on germ cells in the neonatal ovary. 
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Figure 18 | SOX17 expression in the marmoset monkey ovary. Immunohistochemical staining of a marmoset 
(Callithrix jacchus) neonatal ovary (A) and adult ovary (B) for SALL4 (top panel), SSEA-5 (middle panel) and 
SOX17 (bottom panel). Scale bar ≙ 300 µm (all except bottom panel of B), 200 µm (bottom panel of B). 
Results 
 
 
54 
 
Figure 19 | SOX17 expression in the marmoset monkey testis. Immunohistochemical staining of a marmoset 
(Callithrix jacchus) neonatal testis (A) and adult testis (B) for SALL4 (top panel), SSEA-5 (middle panel) and 
SOX17 (bottom panel). Scale bar ≙ 300 µm (A), 200 µm (B). 
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Figure 19 shows the same staining approach as in Figure 18 but in the marmoset neonatal 
and adult testis. SOX17 and SSEA-5 were not detectable in the neonatal testis, while SALL4 
was expressed in the spermatogonia in the seminiferous tubules. In the adult testis, SALL4 
expression was restricted to some spermatogonia, possibly the spermatogonial stem cells, 
while SSEA-5 was expressed in the spermatogonia (pre-meiotic germ cells) and the primary 
spermatocytes (early meiotic germ cells). Interestingly, SOX17 IHC resulted in a staining 
pattern similar to that observed with SALL4 in regard to the cell type, where a fraction of the 
spermatogonia exhibited SOX17 expression. However, SALL4 was detected in the nucleus 
whereas SOX17 signal was detected in the cytoplasm. 
 
Figure 20 | SOX17 expression in the macaque testis. Immunohistochemical staining of a rhesus monkey 
(Macaca mulatta) adult testis (A) and lion-tailed macaque (Macaca silenus) adult testis (B) for SALL4 (top 
panel) and SOX17 (bottom panel). Scale bar ≙ 200 µm (top panel + bottom panel of B), 300 µm (bottom panel 
of A). 
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Finally, adult testes of rhesus macaque (M. mulatta) and lion-tailed macaque (M. Silenus) 
were stained for SALL4 and SOX17 (Figure 20). SALL4 was reliably detected in the 
spermatogonia of both species. In contrast to the marmoset testis, SOX17 was expressed in 
the macaque testis in most meiotic and post-meiotic germ cells (secondary spermatocytes, 
round and elongated spermatids). To better appreciate and compare this finding, higher 
magnifications of adult germ cells of the investigated species are shown in Figure 21, with 
cross sections of the seminiferous tubules from the basement membrane to the lumen 
(Figure 21 B-D). 
 
Figure 21 | SOX17 expression in NHP germ cells. Immunohistochemical staining for SOX17 in a marmoset 
monkey oocyte (A) and seminiferous tubules of the marmoset monkey (B), the rhesus monkey (C) and the lion-
tailed macaque (D). All images higher magnification of images in Figures 15-17. 
2.1.3 Searching for PGC selection and characterisation markers 
2.1.3.1 ANPEP/CD13 is a novel surface marker on marmoset PGCs 
Primordial germ cells can be identified by their expression of pluripotency factors. This was 
confirmed for the embryos isolated in this study as shown in Figure 22. While the available 
NANOG antibody always led to some amount of background staining (Figure 22 B), LIN28 
and SALL4 were still expressed in many tissues of the younger embryos (Figure 22 C+D) and 
were therefore not suitable to identify PGCs in all embryo stages. Previous attempts in our 
lab have shown that marmoset PGCs do not seem to express any of the known surface 
proteins of human and mouse PGCs or ESCs (SSEA-1,-3,-4,-5; TRA-1-60, Tra-1-81). As tested 
before, SSEA-5 was not expressed on marmoset PGCs (Figure 22 E). Only OCT4A was 
specifically and robustly expressed in PGCs of all investigated stages (Figure 22 A) and 
therefore chosen to identify PGCs in all parts of this study. 
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Figure 22 | Pluripotency factor expression in marmoset embryonic gonads. Immunohistochemical staining for 
OCT4A (A), NANOG (B), LIN28 (C), SALL4 (D) and SSEA-5 (E) on tissue sections of a marmoset GD 70 embryo 
(left panel) and a GD 74 embryo (middle and right panel). Asterisks mark the genital ridge. Scale bar ≙ 300 µm 
(left and middle panel), 200 µm (right panel). 
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Figure 23 | Pluripotency factor and ANPEP expression on marmoset PGCs. Immunohistochemical staining for 
OCT4A (A), LIN28 (B), and ANPEP (C) on tissue sections of a marmoset GD 85 embryo. Gl: Gut lumen. Ge: Gut 
epithelium. Asterisks mark the embryonic gonad. Purple arrows highlight clusters of migrating PGCs that can be 
recognised in all three tissue sections. Scale bar ≙ 300 µm (left panel), 600 µm (right panel). 
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Figure 24 | ANPEP expression on marmoset PGCs. Immunohistochemical staining for OCT4A (left panel) and 
ANPEP (right panel) on tissue sections of marmoset embryos at GD 72 (A), GD 75 (B) and GD 85 (C). Gm: Gut 
mesenchyme. Asterisks mark the genital ridge. Scale bar ≙ 200 µm. 
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The work of a colleague suggested Aminopeptidase N (ANPEP, or CD13) to be expressed on 
human germ cell tumours (seminoma). Since seminoma share the expression of several 
genes with PGCs and spermatogonia[113], marmoset germ cells were stained for CD13 
(unpublished data). Staining of marmoset PGCs revealed ANPEP expression on the PGC 
surface. Figure 23 shows sections of a GD 85 embryo stained for OCT4A, LIN28 and ANPEP, 
where individual clusters of PGCs can be nicely identified in consecutive tissue sections 
(purple arrows). By comparison of these markers, the different subcellular localisations of 
the proteins are clearly distinguishable, with OCT4A being in the nucleus, LIN28 in the 
cytoplasm and ANPEP on the cell surface. However, although ANPEP/CD13 was strongly 
expressed on the PGC surface, it is not a specific marker as visible in Figure 23 C. In 
Figure 24, higher magnifications of ANPEP-positive marmoset PGCs are shown, confirming 
that ANPEP can be found on gonadal PGCs (Figure 24 A+B) as well as migratory PGCs 
(Figure 24 C). 
2.1.3.2 CD31 is expressed on the surface of marmoset PGCs 
Platelet endothelial cell adhesion molecule-1 (PECAM-1), or CD31, is usually found on 
endothelial or haematopoietic cells. Since it was also shown to be expressed on migratory 
and gonadal mouse PGCs[114], I wanted to test marmoset PGCs for expression of CD31. As 
Figure 25 shows, the PGCs in the embryonic gonad of GD 74 and GD 85, revealed by OCT4A 
expression, actually also showed CD31 signal on their surface, making this a new potential 
candidate for PGC selection. Additionally, CD31 was expressed on the endothelia of blood 
vessels in the gonad and other parts of the embryo. In the GD 70 embryo, the genital ridge is 
still less condensed and single PGCs spread over a wider area. This together with CD31 
expression in more tissues/more background staining however made it impossible to 
identify the PGCs via CD31 expression in the GD 70 embryo (data not shown). 
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Figure 25 | CD31 expression in the marmoset monkey embryonic gonad. Immunohistochemical staining of 
tissue sections for OCT4A (top panel) and CD31 (bottom panel) in marmoset embryos at GD 74 (A) and 
GD 85 (B). Ao: Aorta. Asterisks mark the embryonic gonad. Scale bar ≙ 200 µm. 
2.1.3.3 Transcription factor PAX5 is not expressed in marmoset PGCs 
Paired box protein 5 (PAX5) is considered to be a master regulator of B-cell development and 
can be found on naive B-cells in the bone marrow and lymphatic organs. Unpublished data 
shown during a conference talk (Dr. Renee Reijo-Pera; XVIth International Workshop on the 
Development and Function of the Reproductive Organs; Münster, Germany, 2015) indicated 
that OCT4 might form a heterodimer in early mouse PGCs with PAX5 instead of SOX2 as in 
pluripotent stem cells. I wanted to test whether PAX5 could also be detected in early 
marmoset PGCs. For this purpose, sequential sections of GD 50 and GD 72 marmoset 
embryos were stained alternatingly for OCT4A to identify the PGCs, and PAX5. The results 
are shown in Figure 26. PAX5 antibody stained cells in marmoset and rhesus bone marrow 
and spleen (Figure 26 C and not shown), confirming that the used antibody is suitable for the 
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detection of the marmoset PAX5 protein. However, no PAX5 was detectable in PGCs of both 
investigated embryonic stages (Figure 26 A+B). 
 
Figure 26 | PAX5 expression in the marmoset monkey embryo. Immunohistochemical staining of tissue 
sections in a marmoset GD 50 embryo (A) and a GD 72 embryo (B). Sequential sections stained for PAX5 (left 
panel), OCT4A (middle panel) and IgG isotype control (right panel). The red boxed areas are shown in higher 
magnification (bottom panel of A). C) PAX5 staining of a marmoset monkey neonatal spleen used as positive 
control for PAX5 expression. Nt: Neural tube. Asterisks mark the developing genital ridge. Scale bar ≙ 200 µm 
(A+B), 60 µm (A bottom panel). 
2.1.3.4 Expression of NLRP7 in oocytes begins around birth 
The cytoplasmic NACHT, LRR and PYD domains-containing protein 7 (NLRP7) is highly 
expressed in the marmoset pre-implantation embryo[115] and marmoset ESCs[14], both of 
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which are part of the germline or germline-derived. As mentioned, many factors expressed 
in the pre-implantation embryo and in ESCs are also expressed in pre-meiotic germ cells. I 
therefore wanted to test the hypothesis that NLRP7 might be a marker of pre-meiotic germ 
cells. 
 
Figure 27 | NLRP7 expression in the marmoset monkey embryo. Immunohistochemical staining for OCT4A 
(left panel) and NLRP7 (right panel) on tissue sections of marmoset embryos at GD 74 (A), GD 75 (B) and 
GD 85 (C). Asterisks indicate genital ridges. Scale bar ≙ 200 µm 
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Figure 28 | NLRP7 expression in the marmoset monkey foetal gonad. A) + B) Histological overview sections of 
a GD 90 ((A), sagittal) and GD 95 ((B), transversal) marmoset foetus. G: Gut, H: Heart, K: Kidney, L: Lung, 
Sc: Spinal cord. Boxed area shows foetal gonad. Scale bar ≙ 4mm (A), 2 mm (B). C) + D) Immunohistochemical 
staining for OCT4A (left panel) and NLRP7 (right panel) on tissue sections of a marmoset GD 90 foetus (C, higher 
magnification of foetus in A) and a GD 95 foetal gonad (D, higher magnification of foetus in B). Inlays in D) show 
higher magnification of a developing seminiferous tubule. Asterisks indicate foetal gonad. 
Scale bar ≙ 200 µm (C, D), 60 µm (inlays in D). 
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Figure 27 shows marmoset embryos of both sexes at different gestational days with PGCs 
marked by OCT4A. No NLRP7 signal could be detected in any of the PGCs. Figure 28 gives a 
histological overview of two male marmoset foetuses cut in the transversal and sagittal 
plane, with the foetal gonad tissues indicated in the blue-boxed areas. A higher 
magnification of the foetal gonads stained for OCT4A and NLRP7 again revealed no NLRP7 
signal in the germ cells but rather in interstitial cells of the foetal testis. Figure 29 shows 
neonatal and adult marmoset gonads stained for NLRP7. VASA and LIN28 stainings are 
included in the neonatal gonads to mark the germ cells. Neither in the neonatal nor the 
adult testis, any signal for NLRP7 was detectable in the germ cells. In the adult ovary, 
oocytes showed strong NLRP7 expression, while in the neonatal ovary already moderate 
signal for NLRP7 could be detected in the cytoplasm of the germ cells. 
 
Figure 29 | NLRP7 expression in adult marmoset monkey gonads. Immunohistochemical staining for NLRP7 on 
tissue sections of a marmoset neonatal ovary (A), neonatal testis (B), adult ovary (C) and adult testis (D). Inlay 
in A) shows VASA staining in the same ovary, inlay in B) shows LIN28 staining in the same testis. 
Scale bar ≙ 200 µm. 
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2.2 Part II – Cell culture studies 
2.2.1 Mouse (Mus musculus) PGC culture 
Mouse embryonic germ cell (EGC)-derivation was attempted to establish the protocol and 
practice before using the very limited marmoset monkey embryo material. Mouse 
embryonic stem cells were cultured in parallel as control (Figure 30). An overview of all 
performed mouse PGC culture approaches during this project is given in Table 4. 
 
Figure 30 | Different AP-staining methods on mouse ESC. A) Mouse C57BL/6 embryonic stem cell colonies 
fixed and stained for expression of Alkaline Phosphatase (purple colour) and unstained control. B) Mouse 
C57BL/6 embryonic stem cell colonies after AP-live stain (green fluorescence) and unstained control. 
Scale bar ≙ 100 µm. 
The initial protocol was based on publications by Durcova-Hills (2008)[101] and De Miguel 
(2011)[68]. Briefly, embryonic genital ridges (GR) and mesonephroi (MN) containing the PGCs 
were dissected from embryos of embryonic day (E) 10.5 to E 13.5. It was also attempted to 
culture a cell suspension of E 8.5 embryo fragments. 
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Table 4 | Overview of all mouse embryo retrieval and culture approaches for EGC derivation. 
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Exemplary images of mouse embryo dissections are given in Figure 31 A+B. GR and MN had 
to be enzymatically digested and cells had to be cultured on special feeder cells that express 
a membrane-bound form of stem cell factor (SCF), which according to literature is essential 
for EGC derivation[97, 98]. If the culture of the PGCs and their conversion into EGCs was 
successful, colonies would appear after 7-12 culture days that express the protein Alkaline 
Phosphatase (AP), which is considered a hallmark of pluripotency. Figure 30 shows pictures 
of mouse ESCs stained for AP-expression with two different methods. Both staining methods 
showed clear AP-signal of undifferentiated ESC colonies. Figure 31 C+D shows a 
representative image of a PGC culture 5 days after cell isolation. Small round structures 
(indicated by arrows) could be observed in the culture plates that were thought to be 
potential colonies. However they did not express AP and did not lead to further colony 
formation when sub-cultured on fresh culture plates. 
 
Figure 31 | Mouse GR isolation and PGC culture initiation. A) Representative mouse E 8.5 embryo. Dotted line 
marks posterior third of embryo which contains PGCs. B) Representative mouse E 12.5 embryo after 
preparation of the urogenital ridges and higher magnification of isolated UGR (right panel). Dotted line 
indicates border between genital ridge and mesonephros. C) Exemplary picture of culture dish 5 days after GR 
culture initiation. Arrows indicate potential cell colonies. Scale bar ≙ 100 µm. D) Higher magnification of 
potential colony in C). Scale bar ≙ 50 µm. 
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To enrich the proportion of PGCs in the starting cell population for the culture, MACS 
purification was performed. The mouse PGCs were labelled using α-SSEA-1 antibody and 
isolated from the GR cell suspension over a magnetic column. The efficiency of the 
enrichment protocol was tested via flow cytometry analysis of the cell suspension before 
and after MACS. Figure 32 shows that the proportion of SSEA-1-positive PGCs of the total 
E 12.5 GR cells was 33.8 %, after MACS a purity of 93.6 % was achieved. Despite the high 
percentage of SSEA-1-positive cells, most likely PGCs, no colonies appeared in the culture. 
Additionally, the quality of the feeder cells was low, with the cells detaching from the plate 
and forming web-like structures instead of an evenly-spread surface for the PGCs to grow 
on. Despite several changes of cell density and the culture medium, the problem with the 
feeder cells could not be overcome. 
 
Figure 32 | FACS analysis of purification efficiency of mouse E 12.5 GR cells. MACS was performed on mouse 
E 12.5 genital ridge cell suspension using α-SSEA-1 antibody to select PGCs. Cells were collected before and 
after the purification process and analysed via flow cytometry. Plots show singlet cells gated for SSEA-1, pink 
number indicates percentage of SSEA-1-positive cells. A) Unstained control. B) Cells before MACS purification. 
C) Cells after MACS purification. 
After switching from mouse embryos of CD1 genetic background to mice of 
C57BL/6-background, AP-positive cell colonies could be detected in one culture approach 
(Figure 33, no colour image available). However, these colonies were not detectable by eye 
and only revealed by their purple colour after AP-staining due to them being formed by a 
monolayer of cells that was hardly distinguishable from the feeder cell layer below. In 
another experiment, one potential EGC colony appeared that could be detected by eye. This 
colony was sub-cultured, but did not lead to the formation of further EGC colonies. 
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Figure 33 | Mouse E 11.5 GR cells 11 days in culture stained for Alkaline Phosphatase. AP-stain revealed 
several AP-positive colonies after C57BL/6 PGCs were purified via MACS and cultured for 11 days. 
A-D) Examples of AP-positive colonies shown in different magnifications. Scale bar ≙ 500 µm (A), 100 µm 
(B+D), 50 µm (C). 
After this, the formation of primary EGC colonies could not be satisfyingly reproduced. 
Therefore, I implemented a more sophisticated culture protocol that I obtained from and 
learned in the group of Prof Hubert Schorle (Department of Developmental Pathology and 
Department of Molecular Diagnostics, Institute of Pathology, Bonn Medical School), where 
they successfully derive mouse EGCs. The protocol is based on a publication by Leitch 
et al.[102]. I also obtained a different line of feeder cells (Sl4-m220) from Prof Schorle’s group 
in an attempt to overcome the feeder quality issues. With the new protocol, primary EGC 
colonies were expected to form after 12-14 culture days. Figure 34 shows an exemplary 
image of a PGC culture dish after 14 days. While colonies seemed to form, they never 
showed the expected morphology with clear colony borders and a smooth surface. Instead 
they seemed to consist of cell clumps with a grainy surface. They also detached easily from 
the feeder cells and there were also many floating structures detectable. 
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Figure 34 | Mouse E 10.5 GR cells 14 days in culture. Exemplary pictures of mouse GR culture plates after 
14 days of culture using the protocol acquired in Bonn. A) Floating structures of unknown identity, possibly 
detached colonies. B) Potential EGC colony still attached to the culture dish. Scale bar ≙ 500 µm (A), 
100 µm (B). 
 
Figure 35 | Mouse E 10.5 GR cells 7 days in culture stained for Alkaline Phosphatase. Mouse GR culture plates 
after 7 days of culture using the protocol acquired in Bonn stained for expression of AP. A) Representative 
picture of mouse GR culture dish. B) Higher magnification of boxed area in A), showing potential colonies 
detach rapidly from the plate surface. C) AP-positive floating EGC colony. D) AP-negative attached colony of 
unknown identity. Scale bar ≙ 500 µm (A), 50 µm (B-D). 
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This problem was already observed after 8 days of culture. AP-stain of such a culture after 7 
days revealed few AP-positive colonies that had detached (Figure 35 C). However, it remains 
unclear whether this happened during the staining progress or already before. Colonies 
remaining attached to the plate showed no AP-signal (Figure 35 D). An attempt to pick and 
sub-culture these primary colonies, both attached and floating, actually led to the formation 
of secondary colonies in 1/8 (12.5 %) of the culture wells. However, also in these colonies no 
clear AP-activity could be detected and their identity as EGCs could not be confirmed 
(Figure 36). 
 
Figure 36 | Potential mouse EGCs 11 days sub-cultured stained for Alkaline Phosphatase. Primary mouse EGC 
colonies from Figure 35 were manually picked and sub-cultured. Appearing secondary EGC colonies were 
stained for AP-expression after 11 days. A) Representative picture of mouse EGC culture dish. B) Higher 
magnification of colony in A). C) + D) AP-stain revealed no clear AP-activity in the potential EGC colonies. 
Scale bar ≙ 500 µm (A), 100 µm (B-D). 
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2.2.2 Common marmoset monkey (Callithrix jacchus) PGC culture 
2.2.2.1 Retrieval of staged marmoset monkey embryos and GR preparation 
In order to obtain marmoset monkey embryos of defined developmental stages, the 
timepoint of ovulation in the female marmosets had to be determined. This was done by 
monitoring the reproductive cycle via blood progesterone levels. The progesterone cycle of a 
representative female common marmoset is illustrated in Figure 37, with progesterone 
levels given on the y-axis and the twice-weekly dates of blood sampling on the x-axis. In the 
natural cycle, blood progesterone levels lie distinctly below 10 ng/ml during the follicular 
phase, and increase significantly to values > 20 ng/ml after ovulation. The day when 
progesterone levels exceed the 10 ng/ml-threshold is defined as the day of ovulation or 
gestational day (GD) 0. This allowed to calculate the exact age of the embryos. Since the 
female marmosets are housed together with a male mating partner, pregnancy usually 
occurs, in which case progesterone levels will remain high throughout pregnancy even after 
the luteal phase. When the females are not pregnant, progesterone levels will decrease 
again after completion of the luteal phase until they reach the baseline levels. It is possible 
to manipulate the reproductive cycle by giving intramuscular doses of the hormone 
Prostaglandin F2α (PGF) as indicated in the graph. This will induce the lysis of the corpus 
luteum, which is the major source of progesterone and essential for the maintenance of 
pregnancy. Hence, luteolysis will terminate the early pregnancy and induce the maturation 
of a new cohort of ovarian follicles. After set-up of a new mating pair, the female 
reproductive behaviour including the initiation of pre-implantation pregnancy was first 
monitored over a period of 2-3 cycles to ensure that both animals were fertile (occurrence of 
pregnancy) and that external regulation of the cycle via PGF was possible. If this was the 
case for a given breeding pair, the day of ovulation was determined and the pregnancy 
continued until retrieval of the embryos at the intended gestational day. It is important to 
note that the GD and the developmental stage do not necessarily correspond exactly, which 
is in contrast to the highly regularly proceeding pre-natal development in mice. Looking at 
the Carnegie stages 10-16, it was observed that at a given GD in the marmoset a variation of 
± 2 stages can occur[116]. The intra-litter variation that was observed at the developmental 
stages isolated in this study was however rather small, which has also been described 
before[116]. 
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Figure 37 | Progesterone values along the reproductive cycle of a representative female common marmoset. 
After set-up of a marmoset monkey mating pair, blood progesterone levels in the female were measured twice 
per week to monitor the reproductive cycle. The black line indicates the ovulation threshold level of 10 ng/ml. 
Black arrows indicate days of external Prostaglandin F2α-administration, which resets the cycle and induces a 
new follicle maturation. The red circle indicates the day of ovulation after which pregnancy prevailed and 
embryos of defined age could be retrieved. 
Figures 38 and 39 give an anatomical overview of the embryos used for this project. The 
Embryo in Figure 38 represents the earliest developmental stages that were used (approx. 
corresponding to Carnegie stages 14-15). Figure 39 shows a GD 85 embryo, which was 
classified as Carnegie stage 20 and was the oldest retrieved stage. Most retrieved embryos 
were measured and weighed and the results are depicted in Figure 40, confirming the inter-
litter developmental variation. 
After obtaining the embryos via caesarean section, they were isolated from the placenta and 
the PGC-containing tissues dissected. Representative images of the dissection process and 
the target tissues are shown in Figures 41 and 42. In Figure 41 A a very small embryo is 
shown, where the urogenital ridges (UGR) cannot yet be separated into GR and MN and 
were therefore treated as one tissue. 
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Figure 38 | Overview of a GD 71 marmoset monkey embryo. Top picture shows a representative GD 71 
marmoset embryo after dissection from the placenta. Bottom image shows a representative histological 
section of the embryo shown in the top picture. Ao: Aorta, Bv: Brain vesicle, He: Heart, Nt: Neural tube, 
Pc: Plexus choroideus, Pe: Pericardium, UGR: Urogenital ridge. 
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Figure 39 | Overview of a GD 85 marmoset monkey embryo. Top picture shows a GD 85 marmoset embryo 
after dissection from the placenta. Bottom image shows a representative histological section of the embryo 
shown in the top picture. Ad: Adrenal gland, Ao: Aorta, Bv: Brain vesicle, E: Eye, Go: Gonad, He: Heart, 
K: Kidney, Lu: Lung, Nt: Neural tube, Oe: Oesophagus, Pc: Plexus choroideus, Pe: Pericardium, St: Stomach, 
T: Tongue, Tr: Trachea. 
Results 
 
 
77 
 
Figure 40 | Graphical representation of the size and weight of the retrieved marmoset monkey embryos. 
Data points represent mean of one gestational day, error bars indicate standard deviation. n = number of 
available embryos per GD with number in brackets indicating the number of litters the embryos came from. 
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Figure 41 | Dissection strategy of marmoset monkey genital ridges and mesonephroi I. A) Picture of a (rather 
small) GD 72 embryo still in the amnion after isolation from the placenta. Right panel shows the urogenital 
ridges after dissection as well as a piece of aorta. B) Picture of an intact representative GD 73 embryo after 
isolation from the placenta. Lower image shows two complexes consisting of kidney, adrenal gland, 
mesonephros and genital ridge after dissection out of the embryo. One is shown from the dorsal side, the other 
from the ventral side. C) Embryo fragment of a GD 75 embryo, lying on the back. Ventral view onto the aorta in 
the middle with the adrenal/kidney/MN/GR-complex on either side. Hl: Hind limb. Lower image shows the 
isolated and separated genital ridges and mesonephroi. Orange arrows show the GR-dissection step-by-step. 
Results 
 
 
79 
 
Figure 42 | Dissection strategy of marmoset monkey genital ridges and mesonephroi II. Isolated adrenal 
gland and kidney of a GD 85 embryo already separated from the mesonephros/genital ridge complex. The red 
arrows show the subsequent preparation steps, the dotted lines indicate the border between MN and GR. Note 
the advanced development of all organs compared to Figure 41. 
An overview of all embryos retrieved for this project and the individual culture approaches is 
given in Table 5. As explained for the mouse PGCs, the culture protocol was based on a 
publication by Leitch, Surani, Smith et al. (2013). GR and MN were isolated, enzymatically 
digested and plated on Sl4-m220 feeder cells until the appearance of primary EGC colonies. 
AP expression was considered necessary for the identification as pluripotent. Established 
marmoset ESCs[14] were cultured as control. Figure 43 exemplarily shows a picture of 
marmoset ESC colonies. The colonies on the right are shown as an example of differentiation 
and were AP-negative. The colony on the lower left was stained positive for AP expression 
(no colour-image available) and shows the typical morphology of undifferentiated 
pluripotent marmoset monkey stem cell colonies: smooth surface and a distinct colony 
border, consisting of densely-packed small cells with a high nucleus-to-cytoplasm ratio and 
visible nucleoli. 
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Table 5 | Overview of all marmoset embryo retrieval and culture approaches for EGC derivation. 
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Figure 43 | AP-positive marmoset monkey ESC colony. Marmoset monkey embryonic stem cells were cultured 
as pluripotent cell control and stained for Alkaline Phosphatase (no colour image available). The colony in the 
lower left part of the image was AP-positive and exhibited the typical morphology of undifferentiated 
pluripotent stem cells. The colonies on the right were AP-negative. The lower right colony is already completely 
differentiated, the upper right colony shows morphological signs of differentiation and is in a borderline 
differentiation state. 
Initially, the GR and MN were digested using varying concentrations of trypsin and then the 
whole cell suspension was plated. Figures 44, 45 and 46 show exemplary microscopy images 
of respective culture plates. From time to time, the formation of roundish cell colonies on 
top of the mouse feeder cells could be observed. The colonies seemed to be a monolayer of 
cells with – morphologically – epithelial characteristics (Figure 44 D+E), as was observed 
sometimes in the mouse PGC culture (Figure 33). However, they never showed any signs of 
AP expression and vanished after several days. Additionally, round structures were also 
formed by the feeder cells (Figure 44 C, 45 C+D), making it difficult to confirm the presence 
of primary EGC colonies. Although trypsin digestion is the published method of choice, I 
suspected that the digestion with trypsin might be too stressful for the cells, or too 
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aggressive in the sense that relevant cell surface receptors might get impaired. Therefore, I 
switched to an enzyme solution consisting of hyaluronidase, collagenase and DNase to 
ensure that predominantly the tissue’s extracellular matrix was digested and not the cells 
themselves. Additionally, DNase was used to digest sticky genomic DNA that was released 
from unintendedly destroyed cells. However, also this more gentle digestion did not lead to 
the formation of cell colonies. Additionally, the problem with the detaching feeder cells 
described for the mouse PGC culture also occurred (Figure 45 A, Figure 46). 
 
Figure 44 | Culture of marmoset GD 71 embryo GR cells. A) + B) Exemplary image of culture dish 2 days after 
culture initiation. No morphological difference can be observed between the feeders-only dish (A) and the well 
containing GR cells (B). C) Feeders-only control culture plate after 8 days of culture. Round structures formed 
by the feeder cells can be observed. D) Round structures/potential EGC colonies can be observed in the culture 
plates containing GR cells after 8 days. A monolayer of cells can be seen on top of the feeder cells (inlay, higher 
magnification of colony border). E) AP-stain after 10 days shows no AP-activity signal in potential colonies. 
Scale bar ≙ 100 µm. 
Results 
 
 
83  
Figure 45 | Culture of marmoset GD 77 embryo GR and MN cells. Exemplary image of culture dish 14 days 
after culture initiation. No morphological difference can be observed between the feeders-only dish (A) and 
the well containing GR cells (B). In both cultures feeders are detaching and form floating cell clusters. 
C) + D) Culture wells containing mesonephros cells. Round structures can be observed (inlay: higher 
magnification of C). AP-stain after 14 days reveals no AP-activity signal in all wells. Scale bar ≙ 100 µm. 
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Figure 46 | Culture of marmoset GD 71 embryo UGR cells. Exemplary pictures of plates cultured for 10 days, 
after implementation of a different enzyme digestion method. There seems to be a difference in feeder cell 
quality between the wells containing UGR cells (A) and feeder cells-only (B), with more and better attached 
feeders in the UGR cell plates. Scale bar ≙ 100 µm. 
2.2.2.2 Purification of live cells using ANPEP antibody fails 
Based on the finding that no PGC-derived cell colonies could be established from the mixture 
of cells obtained from the whole GR (and MN), it was my goal to identify a PGC-specific cell 
surface protein to be able to purify or at least enrich the PGCs from the total cells of GR and 
MN, as has been done for mouse PGCs[101]. As shown in Part I by IHC, PGCs can be identified 
via pluripotency factor expression. However, since they are all intracellular transcription 
factors, they cannot be used to select the cells intact, which is a requirement if they are to 
be cultured further. As mentioned in chapter 2.1.3.1, marmoset PGCs do not express any of 
the known surface markers of human and mouse PGCs or ESCs like the SSEAs and the TRAs. 
When the PGC-specific cell surface expression of Aminopeptidase N (ANPEP, or CD13) was 
confirmed via IHC (Figure 24), an attempt was made to label the GR cell suspension with an 
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α-ANPEP-antibody and sort the cells in a FACS sorter. However, unexpectedly, during the 
sorting no ANPEP-positive cells could be detected (data not shown). Since ANPEP is also 
highly expressed on marmoset ESCs, I decided to use these cells as control to refine the FACS 
labelling and sorting protocol before proceeding with the embryo GR material. The results of 
the ESC-ANPEP flow cytometry test are shown in Figure 47. Compared to the unstained 
control, where a background-level of 0.4 % ANPEP+-cells was measured, the staining of ESCs 
resulted in 3.5 - 3.9 % of total cells being measured as ANPEP-positive. The labelling 
efficiency was independent of the temperature used for antibody-incubation during the 
staining procedure (Figure 47 C-E). Based on IHC and immunofluorescence images 
(Figure 48), I expected > 90 % of the ESCs to be ANPEP+. I first had no explanation for this 
unexpectedly low percentage of ANPEP-labelling, until the idea was brought to me that 
ANPEP as a peptidase might cut the antibody-peptide after it bound. This would mean that 
ANPEP in its intact form on live cells cannot be bound by this antibody. Only fixation in 
Bouin’s solution, as occurs in the tissue preparation for IHC, leads to the inhibition of its 
enzymatic activity and therefore its detectability via antibody-binding. To test this 
hypothesis, marmoset ESCs were stained for ANPEP via immunofluorescence after Bouin-
fixation of the cells as well as on un-fixed, live cells. As a control, an established ESC surface 
marker was used that should not interfere with the antibody even when the cells were still 
intact. For this purpose, the glycoprotein Tra-1-81 was chosen. DAPI-staining was performed 
as an indicator of cell viability, since dead cells are permeable for DAPI and intact cells are 
not[117]. As shown in Figure 48, after fixation Tra-1-81 as well as ANPEP could be detected on 
the cell surface of almost 100 % of ESCs. When the cells remained alive for the staining 
procedure, they suffered stress and the ESC colonies lost their typical morphology. However, 
most of them remained intact until the end of the staining procedure, which can be seen by 
the absence of a DAPI-signal in the cells (Figure 49). Tra-1-81 staining resulted in specific cell 
surface staining of live cells (Figure 49 A), whereas ANPEP was hardly detectable on any cell 
in the non-fixed sample (Figure 49 B). This strongly supports our hypothesis that this ANPEP-
antibody cannot be used to select and enrich live cells. 
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Figure 47 | FACS analysis of different staining approaches for ANPEP (CD13) on marmoset monkey ESCs. 
Marmoset monkey embryonic stem cells were stained for FACS analysis using α-CD13 antibody and 
AlexaFluor488-coupled secondary antibody. Antibody incubations were performed at different temperatures 
as indicated above the plots. Plots in (A) depict the gating strategy to only analyse singlet cells. Plot B) shows 
unstained control cells to position gates for ANPEP-signal. Plots C) – E) show cells gated for ANPEP, purple and 
red numbers indicate percentage of cells per gate of total measured singlet cells. 
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Figure 48 | IF staining of marmoset ESC surface proteins following fixation. Marmoset monkey embryonic 
stem cells were fixed in Bouin’s solution and immunofluorescence staining performed for surface markers 
Tra-1-81 (A) and ANPEP (B). DAPI control staining served as an indicator of cell viability. Scale bar ≙ 50 µm. 
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Figure 49 | IF staining of marmoset ESC surface proteins on intact cells. Marmoset monkey embryonic stem 
cells remained alive for immunofluorescence staining of surface markers Tra-1-81 (A) and ANPEP (B). 
DAPI control staining served as an indicator of cell viability. Scale bar ≙ 100 µm. 
2.2.2.3 Tissue explant culture and culture timeline 
After the failed attempt to purify PGCs for culture, I decided to culture the GR and MN as 
whole-tissue-explants, as has been described for human genital ridges and EGC 
derivation[109]. As shown in Figure 50, the tissues attached nicely to the culture plate and an 
outgrowing (mono-)layer of cells could be observed after several days. However, the 
outgrowths did not exhibit AP-activity after 7 days and sub-culture after 10 days did not lead 
to colony formation. In an attempt to increase the surface for the cells to form monolayer 
outgrowths and potentially start growing as pluripotent cells, the GR and MN were manually 
plucked into smaller pieces and cultured as tissue fragments (Figure 51). However, this also 
did not result in AP-positive cells or colony formation after sub-culture. 
Results 
 
 
89  
Figure 50 | Tissue explant culture of marmoset GD 74 embryo GR and MN. Marmoset monkey genital 
ridges (A) and mesonephroi (C) were plated as intact tissues, attached and microscopy images taken after 
7 days of culture. Scale bar ≙ 500 μm. B) + D) Magnified view of tissue explant border area. The outgrowing 
cells form a distinct monolayer. They do not exhibit AP activity. Scale bar ≙ 200 μm. 
After the described fruitless culture approaches, it was my goal to analyse at which point the 
PGCs vanish. Since the PGCs as well as the desired EGCs should express pluripotency factors, 
I decided to culture GR and MN fragments for a varying number of days and test for the 
presence of pluripotency factor mRNA expression, namely OCT4 and NANOG, via qPCR. As a 
positive control for the detectability of the genes of interest, whole GR were collected 
directly after isolation (Day 0), and the measured expression levels in the GR-cultures were 
related to feeders-only controls cultured for the same amount of time. The results of this 
culture timeline are shown in Figure 52. As expected, high abundance of OCT4 and NANOG 
transcripts were detected in the fresh GR tissue. Surprisingly, low levels of both pluripotency 
factors could be detected in the culture over the period covered by this experiment, 
indicating that some PGCs survive and are detectable in the culture. 
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Figure 51 | Tissue fragment culture of marmoset GD 70 embryo UGR. Marmoset monkey urogenital ridges 
were manually disrupted and plated as tissue fragment explants. A) Images of the intact embryos before 
dissection. B) + C) Microscopy images of tissue fragments taken after 2 days of culture. D) Feeders-only control 
culture plate after 2 culture days. Scale bar ≙ 500 µm (B), 200 μm (C+D). 
 
Figure 52 | Pluripotency factor expression in (U)GR cell culture. (Uro)genital ridge cells of marmoset embryos 
of indicated age were cultured for 2, 4, 8 or 11 days and then collected for qPCR analysis. 18S rRNA was used as 
housekeeping gene and the measured pluripotency factor expression was normalised to feeder cells-only 
controls cultured under the respective same conditions. Whole urogenital ridges were collected for comparison 
(Day 0). 
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3. Discussion 
This study set out to investigate germ cell development in a non-human primate, the 
common marmoset monkey (Callithrix jacchus), via immunohistochemical in situ 
characterisation of marmoset primordial germ cells (PGCs), and attempted PGC culture to 
derive pluripotent marmoset embryonic germ cells (EGCs). Following my investigations, 
ANPEP and CD31 could be confirmed as novel marmoset PGC surface markers. The 
expression of transcription factors PAX5 and SOX17 in early marmoset PGCs could not 
conclusively be demonstrated, however SOX17 staining in adult primate gonads resulted in 
differential staining patterns. NLRP7 could not be confirmed as a primate pre-meiotic germ 
cell marker, but was detected in post-natal oocytes. Analysing PGC migration in mouse and 
marmoset embryos falsified the hypothesis that mammalian PGC migration is generally 
guided by neurons. The culture attempts of marmoset PGCs according to published 
protocols did not result in the establishment of EGCs, leading to the conclusion that 
protocols for successful mouse and human EGC derivation are not suitable using marmoset 
PGCs. 
3.1 Part I – In situ studies of PGC development 
3.1.1 PGCs do not migrate along nerve fibres in marmoset monkey and mouse embryos 
The current comparative analysis of PGC translocation in the marmoset embryo extends and 
quantitates previous observations in the marmoset embryo by Aeckerle et al., 2015, which 
described a wide spatio-temporal (diffuse) distribution of PGCs in the embryo over a large 
portion of the migration period[16]. Furthermore, I included mouse embryos in this 
comparative analysis as a non-primate reference species. In contrast to the marmoset, in the 
mouse embryos the PGCs can be followed during their translocation almost like a regular 
wave or homogenous cohort of cells with predictable locations at different embryonic days. 
As described in the results, the onset of intense PGC proliferation in the mouse embryo can 
be determined histologically by the appearance of clusters of multiple PGCs around the 
gonad on E 11.5, where at the same location only single cells could be observed at E 10.5. At 
the same time the proportion of PGCs found less than 50 µm away from the closest neuron 
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increases from < 2 % on E 10.5 to approx. 5 % on E 11.5. This can be explained by the 
appearance of neurons in the peri-aortic space close to the gonads. Importantly, the data 
indicate that the neurons only appear in the vicinity of the gonad when the PGCs are already 
present in the gonad rather than the other way round. 
Neither in the mouse nor in the marmoset embryos I detected any innervation of the gonad 
before the PGCs arrived there, which is in contrast to the observations in human embryos. 
This is probably the most important finding in this study, since it clearly speaks against the 
hypothesis of peripheral nerves acting as guiding structures for migrating PGCs – as it has 
been described for humans. Published data by Hoyer et al.[93] and Møllgard et al.[94], and 
those presented here rather suggest that nerve fibre-mediated guidance of PGCs is not a 
conserved phenomenon in mammals and may have developed only very recently in primate 
evolution. In this context it is important to mention a study performed by Sasaki et al.[7] on 
cynomolgus monkey (Macaca fascicularis) embryos, which belong to the group of Old World 
monkeys and are therefore evolutionarily even closer related to humans. They investigated 
this question as well by double-staining of migratory PGCs and neurons and came to the 
same conclusion that no structural associations were detectable. 
The markers for the visualisation of PGCs (OCT4) and neurons (TUBB3) were chosen 
carefully. Most importantly, the same markers were used in the human embryo study[94] as 
well as the study in cynomolgus monkey embryos[7], facilitating comparison between the 
different species. As shown several times in this thesis OCT4A can be used to reliably identify 
PGCs. In the study on human embryos by Møllgard et al., TUBB3 was shown to reliably 
detect neurons even in the earliest developmental stages. In the present study, using TUBB3 
resulted in high-quality immunohistochemical stainings with very sensitive and clear signals 
in both investigated species. In fact, the TUBB3 protein sequence between human and 
marmoset TUBB3 is 99.8 % (449/450 amino acids) identical (BLASTP alignment of human 
TUBB3 sequence (Transcript ID ENST00000315491.11) with marmoset sequence (Transcript 
ID ENSCJAT00000009328.3) using Ensembl database 
(https://www.ensembl.org/Multi/Tools/Blast?db=core)), further substantiating the 
comparability of my data and the published data. I therefore feel confident that the selected 
markers and antibodies are well suited to answer the study question. 
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One could argue that inclusion of the PGCs that are already found in the gonads into the 
analysis may bias the results, since they make up a considerable percentage of total cells but 
are no longer migratory. However, looking at the individual developmental days in both 
marmoset and mouse embryos, I see no difference in the percentage of cells that are closely 
associated with neurons, independent of the PGCs’ localisation. For example, on mouse 
embryonic day 9.5, ~ 92 % of PGCs are still migratory outside the gonad, and not a single 
PGC was detected close to a neuron (see Figures 6 and 8). On marmoset gestational day 65, 
only approx. 14 % of PGCs have reached the gonads, but more than 96 % of total cells were 
found in the > 50 µm-distance category (see Figures 2 and 4). From this, I can only draw the 
conclusion that my data set suitably answers the study question, and that PGC migration and 
translocation in the marmoset and mouse embryo are not dependent on peripheral nerve 
guidance to reach the gonad. 
I am aware of the limitations of histological sections as they only allow two-dimensional 
analysis. A closer association between PGCs and nerve cells in the third dimension cannot be 
completely excluded. In order to minimize this problem, consecutive sections of the same 
embryos were analysed to obtain a better spatial resolution, and sagittal as well as 
transversal sections were used to cover all three dimensions. However, to analyse in detail 
and finally prove the spatial relationships between peripheral nerves and PGCs it would be 
favourable to have a three-dimensional representation of the tissues of interest. 
Importantly, however, in the paper by Møllgard et al. a three dimensional representation of 
the embryos was not required to illustrate the close spatial association between neurons 
and PGCs. If these findings would be true also for the marmoset and the mouse it would be 
reasonable to assume that also the same or at least highly comparable methods would be 
sufficient to detect them. 
Using this visualisation method, the possibility that the TUBB3 signal intensity lies under the 
detection threshold, and present neurons might therefore not be visible, can also not be 
excluded. However, I think this is unlikely since (I) another neuronal marker, MAP2, results in 
the same staining pattern via IHC as TUBB3, and (II), again, the findings in the human 
embryos were obtained by the same method and Møllgard and colleagues describe clearly 
detectable nerve fibres[94]. 
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In summary of this part, I find a discrepancy between the published data for the human and 
the data presented here for the marmoset and the mouse. My current conclusion is that the 
reported differences between the marmoset and the mouse on the one hand and the 
human on the other hand represent an evolutionary very recent development in primate 
PGC migration. 
3.1.2 SOX17 shows differential expression patterns in germ cells of non-human primates 
SOX17 is a transcription factor that during embryonic development is important for the 
formation of the endodermal lineage, such as the definitive gut endoderm[83]. But it was also 
shown to be a key regulator of human PGC specification and is expressed even before 
BLIMP-1[76]. In order to test co-expression of both factors in the earliest marmoset PGCs 
available to me, marmoset embryos of GD 49 and GD 53 were stained for OCT4A and SOX17 
to detect cells in sequential tissue sections that probably express both proteins. Indeed, on 
two sets of sequential GD 49 tissue sections, corresponding staining signals could be 
detected in several spots, likely deriving from the same cells. This can however not be 
ultimately confirmed, since the tissue shape on one section deviates slightly from that of its 
neighbouring section due to the embedding, sectioning and staining process. SOX17 staining 
of the GD 53 embryo did not reveal any SOX17-positive cells. 
This method is not suitable to make statements about PGC specification in the marmoset, 
since (I) OCT4A is needed to visually identify the PGCs and OCT4A expression might only 
start downstream of SOX17 expression, and (II) the available marmoset embryos are too old. 
We do not know when PGC specification occurs in the marmoset, but a study in the 
cynomolgus macaque[7] indicates that it occurs as early as GD 11. It is therefore likely that 
SOX17 is expressed in early marmoset PGCs, but that the expression is possibly already 
downregulated when I looked at it. It might also be possible that SOX17 is not at all 
expressed in marmoset PGCs, which would explain why I did not detect it in GD 53 and older 
embryos. Since SOX17 has been implicated in germ cell specification in human and 
cynomolgus monkey, however, I think the first explanation is more likely. 
SOX17 could not be detected in marmoset PGCs at GD 65 and GD 75. Indeed, SOX17 germ 
cell expression must start much later, since new-born marmoset testes and ovaries also 
show no SOX17 staining signal, but adult spermatogonia do. It would be interesting to stain 
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juvenile gonads in order to determine whether SOX17 expression in the germ cells starts 
before or after puberty.  
According to UniProt (https://www.uniprot.org/uniprot/Q9H6I2), after inference of function 
by sequence similarity, SOX17 is a probable transcriptional activator in pre-meiotic germ 
cells. This would fit the expression pattern found in the adult marmoset testis, where SOX17 
was detected in a subset of spermatogonia. Since there is still no known marker to identify 
the spermatogonial stem cells, which is an important goal for reproduction research, SOX17 
might be a candidate and warrants further investigation in that direction. In contrast to this, 
SOX17 was detected in the meiotic and post-meiotic germ cells of the adult marmoset ovary 
and the testes of two investigated macaque species. This is an interesting finding that I 
currently have no explanation for. It might reflect the evolutionary divergence between 
New World and Old World monkeys, since the same staining pattern observed in the 
macaques was also obtained when human testis was stained for SOX17 in our lab (data not 
shown) and in the Human Protein Atlas (HPA; https://www.proteinatlas.org/ 
ENSG00000164736-SOX17/tissue/testis#img). 
In contrast to its role as transcription factor, SOX17 in the investigated NHP gonads was 
primarily found in the cytoplasm, not the nuclei of the cells. I hypothesised that this might be 
due to a change or the absence of a nuclear localisation sequence (NLS). Testing the SOX17 
sequences using the cNLS Mapper tool (http://nls-mapper.iab.keio.ac.jp/cgi-
bin/NLS_Mapper_form.cgi) revealed that indeed in the marmoset sequence no NLS could be 
detected, even if the providers of the tool claim that there might be other NLS’s that are not 
yet recognised by the program. However, the rhesus macaque SOX17 sequence contains the 
same NLS as the human sequence and SOX17 is nevertheless found in the cytoplasm of the 
germ cells, so the subcellular localisation has probably something to do with the protein 
function and not the NLS in the first place. Moreover, there was clear nuclear staining for 
SOX17 in the colon, further supporting the specificity of the antibody 
(https://www.proteinatlas.org/ENSG00000164736-SOX17/tissue/colon#img). 
I wanted to rule out the possibility that the used SOX17 antibody recognises other proteins 
than SOX17 in the tested primate species, which would result in the observed differential 
staining pattern. According to the data sheet, the used SOX17 antibody was raised against an 
epitope of 19 amino acids that in the human is only found in SOX17. A BLASTP of the human 
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SOX17 protein sequence against marmoset and rhesus monkey SOX17 revealed a sequence 
identity of 86 % and 97 %, respectively, with both monkey sequences containing the epitope 
which the antibody recognises. I therefore assume that the SOX17 staining observed by IHC 
is specific. 
3.1.3 Analysis of NLRP7 and miscellaneous potential marker proteins in marmoset germ 
cells 
NLRP7 is thought to be involved in the imprinting process of maternal genes in oocytes, and 
mutations in NLRP7 are associated with pregnancy loss through recurrent hydatiform 
mole[118]. Beside its expression in oocytes, published data of my lab[14] and those of 
collaboration partners[115] have shown high NLRP7 expression in the marmoset 
pre-implantation embryo and marmoset ESCs, suggesting potential germ line-significance, 
which is why I tested marmoset embryonic as well as gonadal tissues for presence of NLRP7. 
Looking at the testes tissues, male germ cells do not seem to express NLRP7, whereas it 
could be detected in oocytes in moderate levels already at birth and at high levels in the 
adult. This finding is in accordance with the reported expression of NLRP7 and its role in 
maternal imprinting in human oocytes[119]. However, human spermatozoa have also been 
reported to express NLRP7 on the mRNA level[120], which is in contrast to what I see in the 
marmoset. I did observe some NLRP7 staining signal in the acrosome of marmoset 
spermatozoa; however, a phenomenon that was observed before is that the acrosome 
unspecifically binds to different antibodies (personal communication by R. Behr), so I 
evaluated the observed staining signal as unspecific. To further clarify NLRP7 expression in 
male marmoset germ cells, it would be possible to perform RT-PCR for NLRP7 on sperm 
samples. In embryonic PGCs of both sexes as well as germ cells in the male foetal gonad, no 
NLRP7 was detected. Unfortunately, no female foetus was available for analysis to further 
investigate the timepoint of the onset NLRP7 expression in oocytes. Since the NLRP7 signal 
in neonatal oocytes was rather low, I speculate however that it does not start long before 
birth. In mice, there is no NLRP7 orthologue, and NLRP7 in the human seems to have 
developed as a homologue to NLRP2 after gene duplication[121]. Therefore, depending on the 
timepoint of this duplication, NLRP7 might be a primate-specific gene and could account for 
developmental differences between mice and primates. 
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PAX5 was investigated in the marmoset because data shown at a conference talk in 2015 
claimed that OCT4 dimerises with PAX5 in mouse PGCs. However, this could not be 
confirmed by the data that I obtained, neither in marmoset PGCs nor in the PGCs of mouse 
embryos (data not shown), and the original mouse data has so far not been published. 
SSEA-5 was first detected as a cell surface glycan on human pluripotent stem cells in 
2011[112], and has since mainly been used for selection and cell sorting[122]. As far as I can 
judge, its biological function is not yet properly investigated. In our group, it has been shown 
to be expressed on undifferentiated marmoset ESCs (unpublished data). Since the absence 
of SSEA-5 from marmoset PGCs has already been confirmed previously by our group 
(unpublished data), it was no primary epitope of interest for me. However, as this side 
project has revealed, SSEA-5 staining leads to interesting detection patterns in the marmoset 
gonad that do not fit its role as a pluripotency marker. For example, it could be detected also 
in primary spermatocytes in the adult marmoset testis, cells which are not associated with 
pluripotency. In the GD 70 and GD 74 embryos it was detected for example on the epithelia 
of stomach, gut, mesonephros and the developing mouth (data not shown). 
I would also like to leave a note for coming experimenters: following antibodies were tested 
at length via IHC (dilution ranges, different tissues) but do not seem to recognise or 
specifically stain the respective protein in Callithrix jacchus:  
Antibody Source Company, Article # 
ANPEP-FITC rHuman Miltenyi #130-103-732 
CD9 Mouse AbD serotec #MCA469GA 
c-Kit Goat Santa Cruz #sc-1494 (M-14) 
c-Kit Mouse ThermoFisher #MA5-12944 (K45) 
D2-40 Mouse Dako #M3619 
DAZL Rabbit Biozol #34139 
DAZL Rabbit Cell Signaling #8042 
DAZL Rabbit Cell Signaling #13057 
ENO2 Rabbit Abcam # ab53025 
GCTM-2 Mouse ThermoFisher #433140 
OCT4 Rabbit Cell Signaling #2750 
SOX17 Mouse Origene #TA500281 
TNAP Mouse Santa Cruz #sc-166261 
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3.2 Part II – Cell culture studies 
3.2.1 Development of the PGC culture protocol 
Protocols for the derivation of mouse and human EGCs are available in the literature and 
describe a multi-step but rather uncomplicated cell line establishment[97, 98, 104]. I therefore 
started the mouse PGC culture approaches to establish this method in our lab and to 
practice GR isolation and culture before beginning experiments with the rare marmoset 
embryo samples. The obstacles encountered and the results of the protocol adaptations are 
described in detail in chapters 2.2.1 and 2.2.2. Especially the low feeder cell quality could not 
be overcome, even by changing the medium composition several times, increasing the 
feeder cell number or mixing different kinds of feeder cells. Adding foetal calve serum (FCS) 
had a beneficial effect on the feeder cells, and should be suitable for mouse EGC derivation 
as described in the protocols. However, FCS did not help in deriving mouse EGCs, and FCS 
was not used for the marmoset PGC culture since experience with marmoset ESCs shows 
that they differentiate as soon as the cells get in contact with FCS. It was stressed in the 
available literature that normal mouse embryonic fibroblasts (MEFs) are not suitable for 
culture, since they do not express the membrane-bound form of stem cell factor (SCF, or 
kit-ligand), which is essential for PGC reprogramming to pluripotency. This is also the reason 
why feeder-free culture was not attempted in this project. 
Apart from the cytokine SCF in its membrane-bound as well as soluble form, the initial 
mouse PGC culture medium that I used contained the cytokine leukaemia inhibitory factor 
(LIF), basic fibroblast growth factor (bFGF) and forskolin[68, 101, 104]. LIF is expressed by the 
trophectoderm and its receptor on the cells of the inner cell mass (ICM)[123], and in culture 
promotes pluripotent cell renewal and inhibits differentiation[124]. bFGF via gremlin induction 
inhibits differentiation signals of bone morphogenic proteins (BMPs)[125], proteins which are 
induced during PGC specification[62], and in culture bFGF induces proliferation in pluripotent 
stem cells[126-128]. Forskolin increases levels of the second messenger cyclic AMP[129]. While 
some available EGC-derivation protocols claim that forskolin is dispensable, the addition of 
the other factors is – understandably – crucial for PGC conversion to the pluripotent state. 
All of these factors were also contained in the medium of the more sophisticated culture 
protocol that was implemented after my visit to the lab of Prof Schorle in Bonn[102]. One 
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difference was that their concentration was initially high in the culture medium and then 
slowly decreased over time as fresh culture medium was added, until finally only LIF, 
CHIR99021 and PD0325901 were added to the medium. The other main difference was the 
addition of two small molecule inhibitors (2i). CHIR99021 is an inhibitor of GSK3 and 
therefore an activator of the beta-catenin/Wnt-signalling-cascade, which induces cell 
division and proliferation[130]. PD0325901 is an inhibitor of MEK and therefore of the 
MAPK-pathway, which usually leads to reduced cell proliferation[131, 132]. While it may seem 
contradictory to use both compounds in the same culture, the so-called 2i medium is widely 
used in different cell culture and differentiation studies[133-135] and has been proven to be 
sufficient for naïve pluripotency in mouse cells[136]. 
Another remaining problem is that AP activity on marmoset PGCs could not yet be 
confirmed, this would however be important as an indicator of PGC culture success. AP-live 
stain of single cells or a GR cell suspension to verify AP expression and identify PGCs was not 
feasible due to autofluorescence. Using the AP-stain on fixed cells would wash away the 
single or unattached PGCs during the staining process, and for IHC of GR in the embryo no 
suitable antibody was available. 
After the failed attempts of marmoset EGC derivation, I wanted to at least roughly analyse at 
which point of the culture the PGCs vanish in order to find new starting points for 
improvement of the culture strategy. As described in chapter 2.2.2.3, GR and MN fragments 
were cultured for a varying number of days and then tested for the presence of pluripotency 
factor expression via qPCR. If EGCs would form and proliferate, I expected to see an increase 
of OCT4 and NANOG expression over time, but since I never saw any colonies I did not 
expect to detect any pluripotent cells remaining in the culture. Surprisingly, there was 
neither an increase nor a decrease of expression levels over time. From this I have to draw 
the conclusion that at least some PGCs remain in the culture, and the problem is getting 
them to properly attach and proliferate, as speculated above. What has to be kept in mind 
when looking at the qPCR-data is that the “Day 0”-amount of cells is not comparable to the 
cultured cells. It was necessary to obtain fresh GR as positive control for the detectability of 
the pluripotency factors, but additionally I should have made a Day 0 culture which would 
also have contained the feeder cells and the appropriate “dilution” of GR cells, as it occurred 
in the other culture samples. Also, due to the rarity of the material, no biological duplicates 
or better triplicates were available. This experiment definitely would have to be repeated in 
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order to make reliable statements about the trajectory of pluripotency factor expression 
levels and hence PGC/EGC culture over time. 
3.2.2 EGCs in the context of germ cell culture 
The failed attempts to culture marmoset primordial germ cells in this study can be seen in a 
wider context of germ cell culture experiments. As elaborated in chapter 1.2, apart from the 
culture of mouse foetal germ cells, namely PGCs, there are also studies that show derivation 
of pluripotent stem cells from neonatal and adult mouse germ cells[51-53]. These reports show 
the potential of post-natal germ cells to convert back into a pluripotent state. Vice versa, 
functional mouse germ cells can now be derived in culture from pluripotent stem cells[137]. 
Therefore, at least in the mouse, trans-differentiation between germ cells and pluripotent 
cells is possible. Studies on the derivation of pluripotent cells from human spermatogonia 
followed soon after the reports on mice[54-57, 138]. The existence of human germ cell-derived 
pluripotent cells is however still debated today. One study was retracted[138] and even the 
persons who initially published such reports have now doubts about the true pluripotent 
state and the identity of the cultured cells[139, 140]. Looking at the situation in non-human 
primates, the culture of adult marmoset spermatogonia did not result in the derivation of 
pluripotent cells[59], and even the culture of younger spermatogonia with supposedly higher 
proliferative potential from neonatal marmoset testes did not yield pluripotent cell lines 
(unpublished data of our lab). The same can be said for the culture of neonatal marmoset 
oogonia[60]. Therefore, the next step for marmoset germ cell culture was to use even 
younger germ cells and thus marmoset PGC culture was attempted in this study. It seems, 
however, that while mouse germ cell culture works relatively well and is widely accepted, 
the derivation of true pluripotent stem cells from human and non-human primate (adult) 
germ cells remains to be demonstrated. 
After performing all these culture experiments I feel that the description of EGC-line 
derivations in the literature is possibly slightly exaggerated. As I have seen in the lab of Prof 
Hubert Schorle, mouse EGC derivation is possible and reproducible, even if I do not think a 
(permanent) cell line in the actual sense can be established. If I should speculate, compared 
to the cells of the blastocyst’s ICM and deriving ESCs, PGCs probably already carry some 
somatic epigenetic marks that do not vanish after spontaneous reprogramming in culture 
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and will therefore at some point reduce the proliferative potential of the EGCs. The same is 
probably true for human EGCs, since no human EGC line is available. This was confirmed 
through personal communication with Prof Neil A. Hanley (Division of Diabetes, 
Endocrinology & Gastroenterology, School of Medical Sciences, University of Manchester, 
UK), who is one of the few who reported human EGC derivation[105, 141]. While this 
disqualifies from my point of view at least human EGCs as true pluripotent stem cells, the 
limited proliferation might still be a valuable feature of these cells and advantage over other 
pluripotent stem cells. One of the biggest problems of pluripotent stem cells for their use in 
regenerative therapy is their unlimited proliferative potential and their potential to form 
specific tumours, namely teratoma. This means that even after differentiation into the target 
tissue, e.g. heart muscle cells, some undifferentiated cells might remain and after 
transplantation into the patients start to form teratoma. EGCs theoretically could be 
expanded over a certain time before they cease proliferation until the cell number is high 
enough, and then safely be differentiated into the target cells. 
3.2.3 The importance of finding a marmoset PGC surface marker 
From the beginning, it was my goal to identify a marmoset PGC-specific surface protein to be 
able to enrich the PGCs in the fraction of cultured cells. This would allow making more 
precise statements about the cells in culture, and additionally help to perform more efficient 
single cell transcriptome analyses. As mentioned before, marmoset PGCs do not seem to 
express any of the known surface markers of human and mouse PGCs or ESCs 
(SSEA-1, -3, -4, -5; TRA-1-60, Tra-1-81), and the task to identify a novel surface marker 
proved rather difficult. I was therefore quite confident when finally PGC surface-specific 
localisation of ANPEP was detected. 
One rather disappointing finding was that ANPEP cannot be used to select and purify live 
PGCs. One possible explanation for this would be that ANPEP is enzymatically active on live 
cells but not Bouin-fixed tissues, so it is detectable via IHC, but the peptidase might cut the 
antibody when it is not fixed. As stated on https://pubchem.ncbi.nlm.nih.gov/target/gene/ 
ANPEP/cattle#section=Orthologous-Genes, ANPEP is a “Broad specificity aminopeptidase 
which plays a role in the final digestion of peptides generated from hydrolysis of proteins by 
gastric and pancreatic proteases. Also involved in the processing of various peptides 
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including peptide hormones, such as angiotensin III and IV, neuropeptides, and chemokines. 
May also be involved the cleavage of peptides bound to major histocompatibility complex 
class II molecules of antigen presenting cells.” This hypothesis was confirmed by 
immunofluorescence, where ANPEP was detectable on fixed but not on intact non-fixed 
cells. 
This leaves the task of finding another PGC-specific surface protein. Unfortunately, CD31 
(PECAM) expression on marmoset PGCs could only be confirmed via IHC very late in the 
course of this project, so that I was not able to test it in vivo on GR cells. This finding forms a 
good starting point for further PGC purification attempts using this surface marker. In the 
original publication, it is shown that CD31 expression on mouse PGCs starts around E 9, 
marking the onset of PGC migration, and ceases after E 13, which is associated with sex 
determination[114]. Since in the marmoset it is not clear at which stage the gonadal PGCs 
start their differentiation into gonocytes, CD31 might potentially be used as a marker for this 
process. Also, mouse PGCs are usually not used for EGC derivation after E 12.5 due to sex 
determination and subsequent loss of EGC-forming potential[68, 101]. Loss of CD31 expression 
in the marmoset could therefore also indicate the point after which the PGCs lose their 
potential for reprogramming in culture. Since I detected CD31 presence on marmoset PGCs 
in the embryonic gonad at GD 74 as well as GD 85, but PGC culture attempts were mostly 
performed with younger embryos of GD 70-74, I am now confident that the used PGCs 
should at least have had the potential to regain pluripotency in culture. 
Indeed, it is not clear whether the age of the used embryos was ideal for EGC derivation. I 
attempted to reach a balance between having as many PGCs as possible in the genital ridges 
at the point of isolation, but isolating them before they start the sex differentiation process. 
In the mouse, this balance point is usually reached at E 10.5 and E 11.5. In the marmoset, I 
judged because of morphological shape and PGC numbers in the GR and decided that 
GD 70-74 should be suitable. I have however no data to confirm this. 
This leaves several potential candidates of surface proteins that are expressed on mouse or 
human PGCs or germ cells, and that remain to be tested on marmoset PGCs: CD38[76], 
CXCR4b[142], CXCR7[143], FGFR3[144] and Ep-CAM[145] were not yet tested. GCTM-2 
(Podocalyxin)[146-148] as well as c-Kit[93], D2-40[149] and CD9[150] were tested, however the 
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available antibodies do not seem to recognise the marmoset proteins, so until a suitable 
antibody can be found, their presence on marmoset PGCs remains unknown. 
3.3 Outlook 
Further marmoset PGC culture attempts are planned. However, to test a new and hopefully 
more promising approach, refined cell culture conditions will be tested. In collaboration with 
Dr Ufuk Günesdogan, marmoset ESCs will first be differentiated into PGC-like cells in vitro in 
order to identify the underlying molecular mechanisms and cell culture requirements for 
PGC differentiation, and then have a better idea how to reverse the germ cell differentiation 
process from PGCs to pluripotent stem cells. 
I also contributed pre-natal marmoset tissue samples to a large EU consolidator grant 
project on comparative developmental genomics coordinated by Prof Henrik Kaessmann 
(Research group Evolution of Mammalian Genomics, ZMBH, University of Heidelberg, 
Germany). We are still waiting for the single cell transcriptome data of the PGCs that will 
also be obtained in the context of this project. With this data, we hope to verify the protein 
expression results obtained in this study by IHC. It might also help to unveil the expression of 
the candidate surface proteins mentioned above, for which no suitable antibody is available. 
If a successful isolation of PGCs with a surface protein can be established, it could also be 
possible to isolate migratory PGCs, and compare the transcriptome of migratory versus 
gonadal PGCs and gonocytes/oogonia after sex differentiation. It would also be desirable to 
compare the transcriptome of mouse and marmoset PGCs to identify additional 
primate-specific characteristics of germ cell development[151]. 
Germ cell development is accompanied by epigenetic reprogramming, and the methylation 
status of promoters of various genes (for example OCT4, VASA, MAGEA4 and the imprinted 
genes MEST and H19) might give new insights into the onset of sex differentiation. 
Therefore, when purification of PGCs is finally possible, a promoter-methylation study could 
be performed as initially intended to determine when the potential for reprogramming of 
PGCs to EGCs is lost. 
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3.4 Summary & Conclusions 
In summary, no spatial association between PGC migration and nerve fibres could be 
observed, neither in the mouse nor the marmoset monkey embryo as a non-human primate. 
This finding falsifies the hypothesis that PGC guidance by developing peripheral nerves is a 
conserved mechanism in mammalian embryonic development. When I compare my findings 
to those obtained in the human embryos, I conclude that the observations by Møllgard et al. 
– other than representing a general mammalian strategy – rather reflect a species-specific 
trait of human PGC development. This must have emerged late in primate evolution. 
Via IHC, I could not confirm NLRP7 as a marker for pre-meiotic germ cells, thereby falsifying 
my hypothesis that NLRP7 could be a primate-specific pre-meiotic germ cell marker. Neither 
could the expression of the transcription factor PAX5 be detected in marmoset PGCs, nor 
could the presence of SOX17 in early marmoset PGCs be definitely demonstrated. Staining of 
SOX17 on adult non-human primate gonads however revealed differential protein 
expression patterns in the primate germ cells that might reflect the evolutionary divergence 
between New World and Old World monkeys. ANPEP and CD31 were confirmed as surface 
proteins of marmoset PGCs via IHC. However, ANPEP was not suitable for purification of live 
PGCs, and CD31 remains to be tested. 
Finally, the attempted derivation of a marmoset EGC line was not successful and I have to 
conclude that the published protocols for human and mouse EGC derivation are not 
effective for marmoset PGCs. 
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4. Materials and Methods 
4.1 Materials 
4.1.1 Solutions and Media 
Bouin’s fixative:  
15 parts Picric acid 1.2 % 
5 parts Formaldehyde 35 % 
1 part Acetic acid 100 % 
 
M10 medium: 
DMEM 
10 % FCS 
0.1 % (v/v) AmpB 
1 % P/S 
2 mM GlutaMAX 
1x NEAA 
 
ESM: 
KO-DMEM 
20 % KO-Serum replacement 
1 % P/S 
2 mM Glutamax 
1 mM MEM-NEAA 
50 µM β-Mercaptoethanol 
 
PGC culture medium (N2B27): 
Equal parts DMEM-F12 + Neurobasal 
medium 
N2 supplement 
B27 supplement 
0.3 % BSA 
1% P/S 
1x Glutamax 
1x NEAA 
100 µM β-Mercaptoethanol 
 
EGC culture medium (2i): 
DMEM-Glutamax 
10 % FCS 
1 % P/S 
200 mM Glutamin 
1x NEAA 
1x EAA 
FACS/MACS buffer: 
1x PBS 
0.5 % BSA 
2 mM EDTA 
 
4x SDS sample buffer: 
8 % (w/v) SDS 
200 mM Tris/HCl pH 6,8 
50 % (v/v) Glycerol 
4 % (v/v) β-Mercaptoethanol 
0.04 % (w/v) Bromphenol blue 
 
10x SDS running buffer: 
250 mM Tris 
1 % (w/v) SDS 
1.92 M Glycin 
 
TBS washing buffer: 
0.05 M Tris 
0.15 M NaCl 
pH 7.6 
 
TBS-Tween: 
TBS  + 0.1 % (v/v) Tween 
 
Anode buffer I: 
0.3 M Tris/HCl pH 10.4 
20 % (v/v) Methanol 
 
Anode buffer II: 
0.025 M Tris/HCl pH 10.4 
20 % (v/v) Methanol 
 
Cathode buffer: 
0.025 M Tris/HCl pH 9.4 
0.04 M Glycine 
20 % (v/v) Methanol 
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4.1.2 Antibodies 
Table I | List of antibodies used for immunohistochemistry
Antibody Source Dilution Company, Article # 
ANPEP (CD13) Mouse 1:50 R&D Systems #498001 
CD31 Mouse 1:100 Dako #M0823 
LIN28 Rabbit 1:200 Cell Signaling #3978 
MAP2 Rabbit 1:150 Sigma HPA012828 
NANOG Rabbit 1:100 Cell Signaling #4903 
Nestin Mouse 1:400 Santa Cruz #sc377380 
NLRP7 Rabbit 1:1000 Abcam #ab117732 
OCT3/4 Rabbit 1:150 Santa Cruz #9081 (H-134) 
OCT4A Rabbit 1:300 Cell Signaling #2890 
PAX5 Mouse 1:150 Dako #M7307 
SALL4 Mouse 1:200 Abcam #ab57577 
SOX17 Rabbit 1:300 ThermoFisher #PA5-23352 
SOX9 Rabbit 1:500 Millipore #AB5535 
SSEA-5 Mouse 1.1000 GeneTex GTX70019 
TUBB3 Mouse 1:2000 Sigma #T8660 
VASA Goat 1:200 R&D #AF2030 
 
Table II | List of antibodies used for Western Blot
Antibody Source Dilution Company 
OCT4A Rabbit 1:500 Cell Signaling #2890 
α-Rabbit-HRP Goat 1:1000 R&D Systems #HAF008 
TUBB3 Mouse 1:2000 Sigma #T8660 
α-Mouse-HRP Goat 1:1000 R&D Systems #HAF007 
 
Table III | List of antibodies used for immunofluorescence, FACS and MACS
Antibody Source Dilution Company 
ANPEP (CD13) Mouse IgG 1:50 R&D Systems #498001 
α-Mouse-IgG-AF488 Goat 1:1000 Invitrogen A10680 
TRA-1-81 Mouse IgM 1:100 eBioscience #14-8883 
SSEA-1 Mouse IgM 1:50 eBiosciences #14-8813 
α-Mouse-IgM-AF488 Goat 1:1000 Invitrogen A10680 
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4.2 Methods 
4.2.1 Obtaining staged marmoset monkey embryos 
All animal studies were performed in accordance with the German Animal Protection Law 
and approved by the ethics committee of the animal welfare office of the Lower Saxony 
State Office for Consumer Protection and Food Safety (Niedersächsisches Landesamt für 
Verbraucherschutz und Lebensmittelsicherheit, LAVES), which is in charge of this approval. 
The animals were obtained from the common marmoset (Callithrix jacchus) breeding colony 
of the German Primate Center (Deutsches Primatenzentrum, DPZ). The institutional 
guidelines on housing and care of marmosets were strictly followed. 
Monitoring progesterone levels in female marmosets: 
Marmoset monkeys were kept in breeding pairs. After set-up of the mating, blood samples 
of the female were obtained twice a week in order to measure the blood progesterone level. 
The hormone assay was performed by the Hormone Laboratory Service Unit of the DPZ. 
During the natural cycle, blood progesterone levels lie distinctly below 10 ng/ml during the 
follicular phase. After ovulation the progesterone levels increase significantly to values 
> 20 ng/ml. The day when progesterone levels exceed the 10 ng/ml-threshold is defined as 
the day of ovulation or gestational day (GD) 0. In case of pregnancy, progesterone levels will 
remain high throughout pregnancy even after the luteal phase, and the exact age of the 
embryos can be calculated. When the females are not pregnant, after the luteal phase 
progesterone levels will decrease again until they reach the baseline.  
Retrieval of embryos via caesarean section or hysterotomy: 
The embryos were obtained at a defined gestational day (GD) via caesarean section or 
hysterotomy typically with survival of the mother animal as described previously[16]. All 
surgical procedures on the animals were performed by a specialised and experienced 
veterinarian. Surgery was performed under anaesthesia under sterile conditions. 
Appropriate analgesic and antibiotic therapy was administered to all animals after surgery. 
The embryos were extracted from the placenta in ice cold PBS (Gibco), weighed and 
measured and the tail frozen for subsequent DNA analysis. The embryos were then either 
fixed in toto for immunohistochemical analysis, or further dissected for cell culture 
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experiments. Marmoset Embryos of GD 49, 50 and 53 and the embryos used for the PGC 
migration study have been previously obtained by our group under license 
#42502-04-12/0708, and were available for histological analysis. 
4.2.2 Retrieval of mouse embryos, gonads and other reference tissues 
Female CD1 mice were obtained from the animal facility of the European Neuroscience 
Institute (ENI; Göttingen, Germany); female C57BL/6 mice were obtained from the animal 
facility of the Max-Planck-Institute for biophysical Chemistry (MPI BPC, Göttingen, Germany), 
at a defined number of days after vaginal plug detection. The mice were sacrificed by 
cervical dislocation and the uterus removed for embryo collection. Embryos for this study 
were obtained at embryonic day (E) 8.5, E 9.5, E 10.5 and E 11.5, respectively. 
Testes and ovaries of different non-human primate (NHP) and rodent species as well as 
other reference tissues for immunohistochemistry were taken from the tissue bank of the 
Platform Degenerative Diseases. All tissues were obtained from animals that had to be 
sacrificed for veterinarian purposes or within the scope of other projects where these tissues 
were not needed and therefore given to us for histological analyses. Additionally, the 
German Animal Protection Law (Tierschutzgesetz) states in §7 Section 2 that the sacrifice of 
an animal for the collection of organs for scientific purposes only is not defined as an animal 
experiment. Thus, scientific organ collection has to be registered with, but not approved by, 
the responsible authorities. 
4.2.3 Immunohistochemistry & Immunofluorescence 
Tissue processing: 
The embryos were fixed directly after retrieval in Bouin’s solution for 4 – 24 hours depending 
on the embryo size. Fixation was followed by several washing steps with 70 % EtOH over at 
least 2 days. Then tissues were embedded in paraffin and sectioned at 5 µm. The embryos 
were positioned in order to obtain either transversal or sagittal sections. 
Immunohistochemical staining: 
Slides for immunohistochemistry were stained using the EnVisionTM Flex Kit by Dako 
(#K8024). Briefly, the slides were deparaffinised in Xylol, rehydrated in a graded Ethanol 
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series and antigen retrieval was performed by heating the slides in 10 µM Na-Citrate buffer 
pH 6.0 (Merck) in the microwave for 10 minutes. Subsequently, endogenous phosphatase 
and peroxidase enzymes were blocked using the blocking agent provided in the kit. Slides 
were washed in TBS and incubated with the primary antibody over night at 4°C in a 
humidified chamber. The antibody signal was visualised the next day using the 
3,3′-diaminobenzidine (DAB+) chromogen. Subsequently, the slides were counter-stained for 
10 – 15 seconds in Mayer’s Hematoxylin Solution, the reaction stopped in 0.1 M HCl, washed 
with tap water and mounted with coverslips using Glycergel (Dako #C0563). Control 
stainings using IgG antibodies at the same protein concentration as the primary antibodies 
were performed in order to exclude unspecific antibody binding. Antibodies used for this 
project are listed in Table I. 
Double-staining: 
Immunohistochemical double-staining was performed in a three-day process using the 
EnVisionTM Doublestain System Kit by Dako (#K5361). The slides were deparaffinised, 
rehydrated and antigen retrieval was performed as described above. The first primary 
antibody directed against OCT4 in mice and OCT4A in marmoset was incubated over night at 
4°C and stained the next day using the 3,3′-diaminobenzidine (DAB+) chromogen. After 
washing and blocking with an agent to prevent double staining of the same antigen, the 
slides were incubated with the second primary antibody against TUBB3 over night at 4°C. All 
incubation steps were performed using a humidified chamber. On the third day, the second 
antibody-signal was visualised using PermanentRed chromogen. The slides were counter-
stained for 10 – 15 seconds in Mayer’s Hematoxylin Solution. Immunohistochemical images 
were taken using the Leica Aperio CS2 Digital Slide Scanner and morphometrically analysed 
with the Aperio ImageScope© software. 
Immunofluorescence staining of cultured cells: 
Marmoset embryonic stem cells (ESCs) were grown in a 6-well plate on glass coverslips. For 
comparison of the staining results of live versus fixed cells, cells were washed twice with PBS 
and then either fixed in Bouin’s solution for 30 minutes at room temperature (RT) or kept 
intact in PBS for the same time. Fixation was followed by blocking the cells with 1 % BSA in 
PBS for 20 minutes at RT. For incubation with the primary antibody, the coverslips were 
Materials & Methods 
 
 
111 
placed in a humidified chamber for 1 hour at 37°C. This was followed by incubation with the 
secondary antibody for 1 hour at 37°C. Primary and secondary antibodies were diluted in 
PBS + 1 % BSA. After each of the previous steps the cells were washed twice with PBS. Cells 
were then incubated with DAPI (0.5 µg/ml diluted in PBS + 1 % BSA for 10 minutes at RT), 
followed by washing with PBS and finally water to remove any salt residues. Coverslips were 
mounted on glass slides in Glycerol/PBS solution AF1 mounting medium (Citifluor #AF1-100). 
Fluorescence microscopy images were taken with a Zeiss Observer Z1 and analysed using the 
AxioVision software (Zeiss). The used primary and respective secondary antibodies can be 
found in Table III. 
4.2.4 Western Blot 
Protein isolation: 
Proteins were isolated from tissues using the Qproteome Kit by QIAGEN (#37582) according 
to manufacturer’s instructions. Using this kit resulted in two fractions: cytosolic and nuclear 
proteins. Protein concentration in the samples was measured using the Bradford assay. 
Briefly, protein samples are incubated with the dye Coomassie Brilliant Blue (BioRad 
#500-0006) and the absorbance at 595 nm is measured in a spectrophotometer. The 
absorbance is proportional to the protein concentration and can be calculated using a 
standard calibration curve of defined BSA concentrations. The calibration curve was 
established using the Nano Photometer Pearl (IMPLEN, Munich) according to the 
manufacturer’s instructions. 
SDS-Polyacrylamide gel electrophoresis: 
The appropriate volume of SDS-sample buffer was added to a sample volume containing 
25 µg of protein and the samples heated at 95°C for 10 minutes to denature the proteins. 
The proteins were then separated according to their molecular weight via gel 
electrophoresis in 10 % polyacrylamide gels using a Minigel-Twin-chamber (Biometra) filled 
with 1x SDS-running buffer. A constant current of 20 mA was provided by the Biometra 
Standard Power Pack P25 for approx. 2 hours. Two size standards were used: the NovexR 
Sharp Prestained Protein Standard (LifeTechnologies #LC5800) for visualisation in the gel and 
on the membrane as well as the MagicMark XP (LifeTechnologies #LC5602), which only 
becomes visible during chemiluminescence detection. 
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Semi-dry protein transfer: 
After gel electrophoresis, the proteins were transferred onto a PVDF membrane (Amersham 
HybondTM-P, GE Healthcare) using a V20 Semi-Dry Blotter Unit (Scie-Plas) for 40 minutes at 
2.4 mA/cm2 gel area (approx. 150 mA/gel). Before the transfer, the membrane had to be 
activated by incubation in Methanol for 5 minutes and the Whatman filter papers had to be 
equilibrated in the respective buffers. A scheme of the transfer set-up is shown below. 
 
 
 
 
Immunodetection: 
After proteins were transferred onto the membrane, it was blocked in TBS-Tween/5 % Milk 
(Tween 20: Sigma-Aldrich #P1379, Milk powder: Roth) for 1 hour at RT on a shaker. 
Incubation with the primary antibody was performed over night at 4°C. On the next day, the 
membrane was washed twice for 5 minutes with TBS-Tween before incubation with an 
HRP-linked secondary antibody for 1 hour at RT and again washed twice with TBS-Tween. 
Primary and secondary antibodies were diluted in TBS-Tween/5 % Milk. Antibodies used for 
western blot analysis are given in Table II. Detection was performed using an Enhanced 
Chemiluminescent solution (AmershamTM ECLTM Western Blotting Analysis System, 
GE Healthcare #RPN2109). The membrane was incubated with 2 ml of ECL solution for 1 min 
ute before detection of the luminescent signal via Intas Chemo Cam and the Chemo Star 
software (INTAS, Göttingen). 
4.2.5 Culture of embryonic stem cells (ESCs) 
Culture of mouse ESCs: 
A commercial mouse embryonic stem cell line (Merck #SCR011, C57BL/6 background) was 
maintained in culture on a feeder cell layer of mouse embryonic fibroblasts (MEFs). MEFs 
were produced by our technical assistants according to established protocols[13] and 
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γ-irradiated to prevent cell proliferation. Embryonic stem cell medium (ESM, all ingredients 
by Gibco) containing 1000 U/ml of mLIF (Gibco #PMC9484) was used to maintain 
undifferentiated ESCs. Medium was changed every other day and cells had to be split every 
2-4 days before the plates became too confluent. For this purpose, cells were detached from 
the plate via incubation in Accutase enzyme solution (Gibco #11599686) for 3 minutes at 
37°C, centrifuged at 200 g for 5 minutes, the resulting pellet resuspended in ESM and 
transferred onto fresh feeder cells. 
Feeder-free cell culture of marmoset ESCs: 
Marmoset ESCs were cultured on Geltrex (ThermoFisher Scientific #A1413302) coated 
6 cm-dishes or 6-well plates with ESC feeder-free culture medium (iPS-Brew XF (Miltenyi 
Biotech #130-107-086) supplemented with 1 µM CHIR99021 (LC Labs #C-6556) and 1 µM 
IWR1 (Sigma #I0161)) at 37°C under 5 % CO2. For Geltrex coating, 2 ml of Geltrex 
(0.16 mg/ml in DMEM (Gibco)) were distributed on the dish and plates were incubated at 
37°C for 1 hour. To maintain ESCs in an undifferentiated state, medium had to be changed 
every day and they had to be split regularly before the plates became too confluent. For this 
purpose, cells were either manually picked under the stereo microscope using a glass tip and 
transferred onto a new plate, or split using Versene solution (Gibco #15040-033). To avoid 
contamination after manual picking, 1 µl/ml penicillin-streptomycin (Gibco #15140-122) was 
added to the medium. 2 mM Prosurvival compund (Merck #529659) was added on the first 
day after splitting or picking of the cells to promote ESC survival. 
All cell culture work was performed under sterile conditions in a flow cabinet. Unless stated 
otherwise, cells were incubated at 37°C and 5 % CO2. 
4.2.6 Culture of primordial germ cells (PGCs) 
Embryo dissection: 
Genital ridges (GR) were dissected from mouse and marmoset embryos of varying 
developmental stages directly after their extraction from the placenta. Embryos were placed 
in ice cold PBS (Gibco) in a plastic petri dish under a stereo microscope. Head, tail and heart 
were removed and frozen in liquid nitrogen for different purposes. The remaining embryo 
fragment was placed on the back and an incision made on the ventral midline. Organs were 
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removed and frozen in liquid nitrogen if they could be identified, then the lateral body wall 
was cut away until the urogenital ridges were visible. The tissue complex of 
aorta/GR/mesonephros (MN) was extracted using micro-scissors. If the developmental stage 
allowed separation, the GR were separated from the MN with fine insulin needles (B. Braun 
Omnican 40). Otherwise the whole urogenital ridge was taken for further culture 
experiments.  
Digestion: 
Depending on the respective protocol, genital ridges were enzymatically digested using 
either trypsin (dilution of 0.5 % Trypsin/EDTA-stock solution (Gibco #15400-054) to final 
concentration of 0.05 % - 0.25 %) or an enzyme mix of 1 mg/ml hyaluronidase (Sigma 
#H2126), 1 mg/ml collagenase IV (Sigma #C5138) and 15 U/ml DNase I (Roche 
#11284932001) diluted in equal parts DMEM-Glutamax and F-12 (Gibco). Digestion was 
performed in wells of a 96-well round bottom plate at 37°C for 5-10 minutes depending on 
the dissociation efficiency. Tissues were dissociated by gentle pipetting, then the cell 
suspension was washed via centrifugation at 200 g for 5 minutes and the resulting pellet 
resuspended in the respective culture medium. 
Depending on the respective protocol, GR and MN were sometimes cultured as tissue 
explants, meaning that they were placed in the culture plate as whole tissues or 
mechanically disrupted to obtain smaller fragments, but not enzymatically digested. 
Culture: 
The obtained GR/MN cell suspension or the tissue explants were plated on 6-well or 12-well 
culture dishes on feeder cells, with the (U)GR cells of 1 embryo per well. Depending on the 
protocol, SNLP-feeder[98] (ATCC #SCRC-1050) or Sl4-m220 cells[97] (Gift of Prof H. Schorle, 
Bonn) were used. The plates had to be prepared 1-2 days prior to culture initiation. For this 
purpose, plates were coated with gelatine for 15 minutes at 37°C, then gelatine was 
removed and plates air-dried. Γ-irradiated feeder cells were thawed in M10-medium and 
distributed on the culture dish to achieve a 90-95 % confluency (approx. 10x104 cells/cm2). 
After 24 hours, the feeder cells had attached to the plate and the M10 medium could be 
replaced with PGC culture medium. Ideally, the culture medium should be placed on the 
feeder cells at least 4 hours prior to the GR cells to allow “conditioning” of the milieu.  
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The development of the culture protocol is illustrated more detailed in the results part. 
However, there are roughly two different protocols that were followed: 
(1) Protocol based on publications by Durcova (2008)[101] and De Miguel (2011)[68] 
(2) Protocol based on publication by Leitch, Surani, Smith et al. (2013)[102] 
Protocol (1) was initially used for culture of mouse PGCs. Cells were cultured on SNLP-feeder 
cells in ESM containing mLIF (1000 U/ml, Gibco #PMC9484), bFGF (20 ng/ml, Prospec 
#CYT-386), mSCF (10 ng/ml, Prospec #CYT-275) and forskolin (10 µM, LC Labs #F-9929). 
Medium was changed daily, wherein 2/3 of the old medium were removed and replaced 
with new medium containing freshly added growth factors. Plates were observed regularly 
for the appearance of embryonic germ cell (EGC) colonies. Colony formation was expected 
to start after 7 days. Appearing colonies were manually picked under a stereo microscope 
using a fine glass tip and transferred onto a fresh plate with mouse embryonic fibroblast 
(MEF) feeder cells. MEF-feeder cells were produced by our technical assistants according to 
established protocols[13] and were plated as described above. The sub-cultured EGC colonies 
were cultured in ESM containing 1000 U/ml of mLIF. 
Protocol (2) was recommended for EGC derivation by Prof H. Schorle and was tested for 
mouse and marmoset PGC culture. Cells were cultured on Sl4-m220 feeders in 
N2B27-medium (all ingredients by Gibco) with dynamic concentrations of growth factors. 
Initially the following components were added to the N2B27-stock medium: bFGF (25 ng/ml, 
Prospec #CYT-275 (m)/#CYT-218 (h)), LIF (1000 U/ml, Gibco #PMC9484 (m)/Peprotech 
#300-05 (h)), SCF (100 ng/ml, Prospec #CYT-275 (m)/#CYT-255 (h)), forskolin (10 µM, LC Labs 
#F-9929), retinoic acid (2 µM, Sigma #R2625) and GSK3-Inhibitor CHIR99021 (LC Labs 
#C-6556, 3 µM for mouse, 1 µM for marmoset PGCs). After 48 hours, one volume of freshly 
prepared PGC growth medium (N2B27-stock medium with LIF (1000 U/ml), CHIR99021 
(3 µM/1 µM) and MEK-Inhibitor PD0325901 (1 µM)) was added. After 4 days, half of the old 
medium was replaced with fresh PGC growth medium, thus continually diluting the initial 
growth factor concentrations. After 6 days, medium was changed completely and fresh PGC 
growth medium was supplied every two days. EGC colonies were expected to form 12-16 
days after culture initiation. Appearing colonies were manually picked under the stereo 
microscope and transferred into wells of a 96-well round bottom plate for digestion with 
0.05 % Trypsin/EDTA (Gibco #15400-054) for 3-5 minutes at 37°C. After pipetting up and 
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down to dissociate the colonies, cells were transferred onto fresh 48-well plates with MEFs 
and cultured in 2i-medium, which was changed every 2-3 days. 
All cell culture work was performed under sterile conditions in a flow cabinet. Unless stated 
otherwise, cells were incubated at 37°C and 5 % CO2. 
4.2.7 Alkaline Phosphatase staining 
Alkaline Phosphatase (AP) expression is considered a hallmark of pluripotent stem cells and 
used as a means to verify EGC identity[97]. AP enzymatic activity can be detected via 
substrate formation using commercially available kits either on PFA-fixed cells (Merck 
#SCR004) or on live cells (Molecular Probes #A14353). Kits were used according to 
manufacturer’s instructions. 
4.2.8 Flow cytometry and cell sorting 
Fluorescence associated cell sorting: 
Flow cytometry and fluorescence associated cell sorting (FACS) requires single cell 
suspensions. For this purpose, genital ridge tissue was digested using an enzyme solution 
(Equal parts DMEM-Glutamax and F-12 (Gibco) containing 1 mg/ml hyaluronidase (Sigma 
#H2126), 1 mg/ml collagenase IV (Sigma #C5138) and 15 U/ml DNase I (Roche 
#11284932001)). After 10 minutes at 37°C, tissues were carefully pipetted up and down to 
dissociate the cells, and finally passed through a 35 µm-cell strainer (Corning #352235) to 
create single cells. Marmoset ESCs were detached from their culture plates using Accutase 
enzyme solution (Gibco #11599686) for 4 minutes at 37°C and passed through a 35 µm-cell 
strainer to create a single cell suspension. After washing the cells with FACS buffer and 
centrifugation at 200 g for 5 minutes, cells were counted and distributed to FACS tubes 
(Corning #352235) with at least 1x105 cells/tube. Cells were incubated with the primary 
antibody for 1 hour at 4°C if not indicated otherwise, washed twice with FACS buffer and 
incubated with a fluorochrome-coupled secondary antibody for 30 minutes at 4°C if not 
indicated otherwise. Primary and secondary antibodies were diluted in a total volume of 
50 µl FACS buffer per tube. Antibodies used for this project are given in Table III. After 
staining the cells were washed, resuspended in 200 µl FACS buffer and either analysed using 
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a LSR II flow cytometer (BD Biosciences) or sorted using the SH800S Cell Sorter (Sony 
Biotechnology). Flow cytometry plots were analysed using the FlowJo software (FlowJo, LLC). 
Magnetism associated cell sorting: 
Magnetism associated cell sorting (MACS) was used to purify mouse PGCs from total genital 
ridge cells. A single cell suspension was created as described above. After counting the cells, 
MACS was performed according to manufacturer’s instructions (Miltenyi Biotec). Briefly, 
cells were incubated in MACS buffer containing the primary antibody against the target 
surface protein for 30 minutes at 4°C, washed twice and incubated at 4°C for 15 minutes 
with magnetic microbeads directed against the primary antibody (Miltenyi #130047302). The 
cells were then passed through a magnetic column (Miltenyi #130-042-201) to retain the 
magnetically-labelled target cells and after removal of the magnet flushed out of the 
column. Target cells were then cultured as described in chapter 4.2.6. A list of antibodies 
used for this project is given in Table III. 
4.2.9 PCR for sex determination of marmoset embryos 
Isolation of genomic DNA: 
Genomic DNA (gDNA) from marmoset embryo tissue was isolated using the DNeasy Blood 
and Tissue Kit (Qiagen # 69506) according to manufacturer’s instructions. 
Photometric quantification of nucleic acids: 
Photometric quantification of nucleic acids was carried out with the Nano Photometer Pearl 
(IMPLEN, Munich) according to the manufacturer’s instructions. 
Amplification of target genes: 
The target genes were amplified via polymerase chain reaction (PCR) using Taq Polymerase 
(NEB #M0273S) according to manufacturer’s instructions. One PCR preparation of 25 µl total 
volume contained 200 ng of gDNA as well as 1x Taq standard buffer, 200 µM dNTPs (NEB 
#N0447S), 0.2 µM of each primer and 1.25 units of Taq polymerase. PCR reaction was carried 
out in a Biometra T300 Thermocycler under following conditions: Initial denaturation at 95°C 
for 30 seconds, followed by 35 cycles of denaturation at 95°C for 30 seconds, annealing at 
the respective appropriate temperature for 15 seconds and elongation at 68°C for 
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1 minute/kilobasepair. After a final extension at 68°C for 5 minutes samples were cooled 
down to 8°C. Primer sequences and annealing temperatures are given in Table IV. Annealing 
temperatures were calculated using the Tm calculator tool by ThermoFisher 
(https://www.thermofisher.com/de/de/home/brands/thermo-scientific/molecular-
biology/molecular-biology-learning-center/molecular-biology-resource-library/thermo-
scientific-web-tools/tm-calculator.html). 
Table IV | Primer sequences for gDNA amplification
Target Primer Name, Sequence (5’  3’) PCR-Product 
Size 
Annealing Temp. 
Beta-Actin 
G0334 fwd.: CAC TCT TCC AGC CTT CTT TCC 
177 bp 51°C 
G0335 rev.:  GTG ATC TCC TTC TGC ATC CTG 
DDX3 
G2108 fwd.: GGW CGR ACT CTA GAY CGG T X = 176 bp 
49°C 
G2109 rev.:  GTR CAG ATC TAY GAG GAA GC Y = 137 bp 
 
Agarose gel electrophoresis: 
The amplified DNA fragments were separated according to their size in a 2 % (w/v) agarose 
gel. The agarose (Biozym) was boiled in 1x TAE buffer (Roth) until completely dissolved, and 
after cooling ethidium bromide was added to a final concentration of 1 μg/ml. The solution 
was poured into a tray and left to solidify for 15-30 minutes. The appropriate volume of 
loading dye (NEB #B7024S) was added to the DNA samples. As a size standard the 
Quick-Load 100 bp DNA Ladder (NEB #N0467S) was used. Electrophoresis was performed in 
1x TAE buffer (Roth) at 100 V for 45 min in a Mupid©-ex electrophoresis system. DNA bands 
were visualised under UV light (302 nm) in the Intas Gel Documentation Station (INTAS, 
Göttingen). 
4.2.10 Analysis of gene expression of cultured cells 
RNA isolation: 
RNA was isolated from frozen cell pellets using the TRIzol/Chloroform method. All working 
steps were performed on ice. Briefly, 1 ml of TRIzol solution (Ambion by life technologies 
#15596026) was used to lyse the cell pellet in a Tissue Lyser LT (Qiagen) for 1 minute. 200 µl 
Chloroform (Merck) was added, the sample vortexed and incubated on ice for 10-15 
minutes. Following centrifugation at 12000 g for 15 minutes, three phases had formed in the 
reaction tube. The upper phase containing the RNA was transferred to a new tube, 1 ml of 
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75 % EtOH was added and the sample incubated at -20°C for 30 minutes. After 
centrifugation at 12000 g for 10 minutes the resulting RNA-pellet was washed twice with 
1 ml 75 % EtOH, dried and resuspended in 30 µl nuclease-free water (Qiagen #129115). To 
remove any traces of remaining DNA, the DNA-free kit (Invitrogen #AM1906) was used 
according to manufacturer’s instructions. 
cDNA generation: 
To generate cDNA from isolated RNA, the Omniscript RT Kit (Qiagen, #205113) was used 
according to manufacturer’s instructions. Additionally to the Oligo-dT primers from the kit, 
Random Hexamer Primers (Thermo Scientific #SO142) were added to a final concentration of 
1 µM. For the reverse transcriptase (RT) reaction 1 μg of RNA was used, resulting in a final 
cDNA concentration of 50 ng/ml. 
Real-time quantitative PCR: 
Real-time quantitative PCR (qPCR) was performed on the StepOnePlus System (Applied 
Biosystems). For each qPCR reaction, 10 ng of template cDNA was mixed with Power SYBR 
green master mix (Applied Biosystems #4367659) and respective pimers with a final 
concentration of 600 nM. Sequences of the used primers can be found in Table V. All qPCR 
reactions were measured in technical triplicates to reduce technical measurement errors. 
The obtained data for each gene of interest was normalised against the housekeeping gene 
18S rRNA. The collected qPCR data was analysed using Microsoft Excel. 
Table V | Primer sequences for qPCR
Target Primer Name, Sequence (5’  3’) 
NANOG 
G0883 fwd.: TCTTCAGCAGATGCAAGAACTTT 
G0884 rev.:  GGTTTTGGAACCAGGTCTTCAC 
OCT4 
G0963 fwd.: GCCAGGGCTTTTAGGATTAAGTT 
G0964 rev.:  TGCCCTCACCCTTTGTGTTC 
18s rRNA 
G1197 fwd.: CACCAAGAGGGCAGGAGAAC 
G1198 rev.:  TGGATTCTGCATAATGGTGATCA 
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